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The best known way of controlling or changing the behaviour of male dogs is through castration (Hopkins et al., 1976). Surgical castration is the most widely used method. However, this method is not always desirable for different reasons. First, a surgical castration is irreversible and there are no guarantees that a desired behavioural change will occur after surgical castration. Furthermore, an operation is not desirable for dogs with a high anaesthetic risk. And for some dog owners operating a healthy animal is not an option. So there is need for a different method of changing the behaviour of male dogs. Nowadays there is a reversible alternative method for surgical castration: chemical castration. This new castration method is still in it’s infancy when it comes to the effect on the behaviour of the male dog. 
In this literature study a review of the normal endocrine situation before and after castration will be given. The activity of chemical castration and the different GnRH agonists that have been evaluated in the dog will be discussed. Furthermore, a review will be given of the literature concerning the effects of surgical castration on the behaviour of the male dog. 
This paper is part of a study that will take several years to be completed. The results displayed will therefore be an initial report of the results found so far.  
The complete study was set up to determine the effect of a chemical castration on the behaviour of intact male dogs using Suprelorin® (4,7 mg deslorelin) and to determine if this effect is comparable with the effect of surgical castration on the behaviour of male dogs. Identifying the consequences of continuous administration of synthetic GnRH (deslorelin) for the endocrinology of the hypothalamus-pituitary-testes-axis is also a subject in this study. The assumption was made that the use of the GnRH agonist deslorelin for chemical castration and surgical castration will cause similar behavioural changes in male dogs. The study was preceded by a pilot study to see if the behavioural effects of treatment with deslorelin would be promising. This pilot study will also be displayed in this paper. 


1.2. Endocrinology  

1.2.1. Normal situation before castration

Reproduction is regulated by an interaction between the nervous system and the endocrine system: the hypothalamus-pituitary-testis-axis (figure 1). 





Spermatogenesis and production and secretion of hormones are therefore performed by the hypothalamus, pituitary and testis. The normal spermatogenic cycle in dogs lasts for about 9 weeks (Trigg et al., 2006). Testosterone is secreted by Leydig cells in response to LH stimulation (Johnston et al., 2001). After binding of LH, the Leydig cells first produce progesterone, which is converted to testosterone (Senger, 2003). A LH peak is followed by a testosterone peak in the peripheral blood of the male dog. The interval between these peaks is relatively constant and is approximated at 50 minutes (DePalatis et al., 1978). The secretion of testosterone is pulsatile and can last for up to 20 to 60 minutes in the male dog (Senger, 2003). 
FSH is important for the normal functioning of Sertoli cells. Testosterone, secreted by Leydig cells, enters the Sertoli cells which have a high density of androgen receptors (Berne et al., 2004). An androgen-binding protein is formed in these cells. This is stimulated by FSH (Johnston et al., 2001). High intratesticular testosterone concentrations, necessary for spermatogenesis, are maintained by binding of testosterone to this protein (Johnston et al., 2001). The intratesticular testosterone concentrations can be 50- to 100-fold greater than in plasma (Berne et al., 2004). Furthermore, testosterone is converted to estradiol by Sertoli cells. They also produce the hormones inhibin and activin (Senger, 2003; Berne et al., 2004). These hormones have a central feedback role in the inhibition and stimulation of the FSH secretion (see below) but can also have a reciprocal effect on their neighbouring Leydig cells. Namely, FSH can indirectly influence the Leydig cell function through the production of inhibin and activin by the Sertoli cells: the testosterone secretion by the Leydig cells can be increased by inhibin and decreased by activin (Berne et al., 2004).  
The interactions between Leydig cells and Sertoli cells can be seen in figure 2.


The release of GnRH is regulated by various influences. The plasma concentration of testosterone exerts a negative feedback effect on the hypothalamus. High plasma concentrations of testosterone cause a decrease in the production and release of GnRH. Low concentrations cause an increase in the production and release of GnRH. The plasma concentration of testosterone also has a negative feedback on the anterior pituitary (Knol et al., 1989). Estradiol and inhibin, coming from Sertoli cells, both have a negative feedback on the hypothalamus (Senger, 2003). The inhibin secretion by Sertoli cells is increased if the spermatogenesis is too brisk. This will cause an inhibition of the GnRH and FSH secretion. In turn, this will lead to a decrease in sperm production. If the spermatogenesis is inadequate the inhibin secretion will be reduced (Berne et al., 2004). In the hypothalamus the GnRH neurons are closely associated with dopamine neurons. LH secretion is inhibited by dopamine by decreasing the release of GnRH and by acting on the gonadotrophs directly (Berne et al., 2004). For a overview of these negative feedback mechanisms see figure 1.  

In a study by Post (1982) a mean basal plasma concentration of testosterone of 622 ± 353 pg/ml was found (Post, 1982). After a challenge test the concentration of testosterone can reach levels above 1000 pg/ml. The concentration of testosterone mentioned in literature dependents on the way it is measured; basal values, mean values or values after a challenge test (Personal communication; Jeffrey de Gier, 2008). 	


1.2.2. Changes after castration

Surgical castration causes a rapid decrease of the plasma concentration of testosterone, progesterone and estradiol in male dogs. The concentration of testosterone will decrease significantly in dogs within four hours after surgical castration (Post, 1982). After surgical castration of guinea pigs it takes only 10 minutes for the testosterone concentration to drop significantly, no measurable quantity of testosterone is present 6 hours after the removal of the testis (Resko, 1970). 
A study by DePalatis et al. (1978) showed that surgically castrated male dogs have higher mean peripheral plasma concentrations of LH than intact male dogs. Surgical castration, however, does not alter the rhythm of pulsatile LH secretion. The mean interval between LH peaks is similar in surgically castrated and intact male dogs (DePalatis et al., 1978). This result was also found in castrated pigs: the concentration of LH gradually increased and reached a higher level than intact pigs 41 hours after gonadectomy (Xue et al., 1994). An increase in GnRH and LH levels in the blood was also seen in ferrets after surgical castration (Vinke et al., 2008). 

A normal functioning hypothalamus-pituitary-testis-axis is necessary for spermatogenesis (Berne et al., 2004). Continuous administration of a synthetic GnRH-agonist used for chemical castration will cause a constant high level of GnRH, as compared to the physiological pulsatile secretion pattern. This will cause a desensitisation of the pituitary for stimulation by GnRH. Production and secretion of LH and FSH will eventually decrease (Inaba et al., 1996; Junaidi et al., 2003; Gobello, 2006; Junaidi et al., 2007). 
Two phases can be seen after chemical castration using a GnRH-implant. During the initial phase the plasma concentration of LH will rise which will result in an increase of the plasma concentration of testosterone. The duration of this increase dependents on the GnRH agonist used. The course of the second phase can be different depending partly on the species (see 1.3.1. introduction). In dogs this phase will cause a decrease in the plasma concentration of testosterone (Inaba et al., 1996; Junaidi et al., 2003; Gobello, 2006; Junaidi et al., 2007). 






There is need for reversible, anti-fertility agents that are safe and less invasive than surgical castration for dogs. To be acceptable, these anti-fertility agents must interfere with fertility without side-effects during use. Side-effects also need to be negligible after cessation of treatment for the treated dog and for the offspring (Junaidi et al., 2003). Furthermore, drugs used for reproductive management have to be long-acting, reliable and easy to use (Trigg et al., 2001). 
An alternative for surgical castration is chemical castration by a potent GnRH agonist like mentioned before. These agonists have a higher affinity and a longer half-life in circulation than natural sequence GnRH (D’occhio et al., 2000). The use of GnRH agonists has been investigated extensively (Trigg et al., 2001). More than 2000 GnRH analogues were developed and tested over the last 30 years for the use of reproduction control in animals. Whether pro-fertility or anti-fertility effects are induced is determined by the interactions between agonist potency, duration and dosage of the treatment (Padula, 2005).
The most popular GnRH agonist at this time is deslorelin. Deslorelin is an efficient GnRH agonist with little side-effects (Trigg et al., 2006). 

GnRH agonists act by suppressing the function of the hypothalamus-pituitary-testis-axis (Trigg et al., 2006). At first the production and release of gonadotrophins from the pituitary is stimulated similar to the action of endogenous GnRH. After this period the axis is inhibited when GnRH is administered in sustained doses. This continuous release of the agonist will cause a downregulation of GnRH receptors in the anterior pituitary and a desensitizing of the pituitary gonadotrophs to endogenous GnRH. This will result in a reduction of the secretion of LH and FSH from the gonadotrophs. After the agonist is cleared the effects will be reversed (Inaba et al., 1996; Junaidi et al., 2003; Gobello, 2006).
Changes in testosterone concentration after the administration of a subcutaneous GnRH agonist can be explained in two ways: it can be a simple passive response to changes in LH secretion or it can be the result of a change in the responsiveness of the Leydig cells to LH (Junaidi et al., 2007).
A major disadvantage of GnRH agonists is that they must be administered by frequent injections or by a slow release implant over a longer period of time to exert their antagonistic properties. Multiple daily administration is acceptable only for research purposes (Inaba et al., 1996). The development of slow-release formulations that can be implanted subcutaneously was therefore a major advantage (Gobello, 2006).

GnRH agonists can show great variation in the endocrine outcome in different species. Treatment with a GnRH agonist will cause a reduction of the LH and testosterone concentration and an involution of testes and accessory sex glands in canines, mice, pigs, ferrets, sheep, horses and rhesus monkeys (Lincoln et al., 1986; Boyle et al., 1991; Kher et al., 1994; Xue et al., 1994; Schneider et al., 1998; Schoemaker et al., 2008). On the contrary, red deer stags show an increase in both LH and testosterone secretion after subcutaneous administration of buserelin. Treatment of bulls with leuprolide, buserelin or nafarelin only causes an increase in the plasma concentration of testosterone, the LH concentration remains at normal values. Treatment of marsupials with deslorelin also causes an increase in the plasma concentration of testosterone while the concentration of LH remains at normal values (Vickery et al., 1985; Lincoln, 1987; Ronayne et al., 1993; Herbert et al., 2004; Junaidi et al., 2007). It is likely that animals like bulls have different regulatory mechanisms at the testicular level for the control of testosterone secretion (Ronayne et al., 1993).  
Despite all these different outcomes, the agonists are generally all thought to work in the same way like mentioned before. In every species of animals there is a downregulation of GnRH receptors in the anterior pituitary and a desensitizing of the pituitary gonadotrophs to endogenous GnRH. In the largest part of male animals this is followed by a reduced secretion of FSH and LH leading to a reduced production and secretion of testosterone. Eventually this will lead to an abolishment of spermatogenesis (Aspden et al., 1998). These animals (canines, mice, pigs, ferrets, sheep, horses, rhesus monkeys) treated with a GnRH agonist show a loss in responsiveness to a challenge with native GnRH (Vickery et al., 1984; Junaidi et al., 2007). Paradoxical observations are seen in bulls, marsupials and red dear stags treated with a GnRH agonist (like mentioned before). In bulls the concentration of LH can be normal or elevated after administration of an agonist, always associated with an increased testosterone concentration. There is a 4-fold increase of testicular LH receptors during treatment with an agonist. This can be the result of a lack of LH pulsation which is normally necessary for the downregulation of LH receptors. This increase in LH receptors can possibly cause an increase in steroid genesis in bulls. However, rats treated with an GnRH agonist show a decreased pulsation of LH together with reduced numbers of LH receptors (Aspden et al., 1998). The potency of the GnRH agonist used could also be important. Therefore, in different studies different agonists (which all have different potencies) have been used in bulls without a difference in the outcome. Furthermore, different dosages have been used, also without success. So the potency (different types of agonists) and the dosage used does not seem to be the explanation for the lack of testosterone suppression in bulls. The cause of an increased testosterone secretion after the administration of a GnRH agonist in bulls remains unclear (Ronayne et al., 1993). The increase of testosterone after GnRH treatment in red dear stags and in marsupials also remains unclear (Lincoln, 1987; Herbert et al., 2004).    

There is a correlation between testosterone and testis volume. A decline in the concentration of testosterone is followed by a decrease in testicular size after the use of buserelin in dogs, rams, monkeys, pigs, mice and ferrets (Vickery et al., 1985; Lincoln et al., 1986; Ronayne et al., 1993, Xue et al., 1994; Kher et al., 1996; Schoemaker et al., 2008). For these animals this correlation  can be used in practice. The owners of an animal can see when the implant is not active anymore once the testis size starts to increase (Ronayne et al., 1993).
On the other hand, an increase in testosterone concentration in bulls after the administration of a GnRH agonist is associated with an increase in testicular volume (Aspden et al., 1998). This association is also found in red deer stags and in marsupials (Lincoln, 1987; Herbert et al., 2004).

Just like GnRH agonists, GnRH antagonists could also be used for the control of reproduction. GnRH antagonists cause a complete block of the receptors in the anterior pituitary (Valiente et al., 2007). They need to have a high affinity for the GnRH receptors without activating these receptors (Padula, 2005). Their action results in an immediate inhibitory effect on the gonadal axis. The antagonists cause no initial stimulatory effect, which is a major advantage over agonists (Valiente et al., 2007). Their widespread use is partly inhibited because a few of these antagonists are associated with a significant histamine release. Furthermore, the development of GnRH antagonists has lagged behind that of agonists because of the high cost of production (Padula, 2005). 
Information about the effect of the antagonists on the reproduction of male dogs is scarce and limited. Nowadays there are three generations of GnRH antagonists. Third generation GnRH antagonist are more potent and safer than first and second generation antagonists. Furthermore, high dosages are necessary to completely inhibit responses to endogenous GnRH when first or second generations are used. In the first study involving a second generation GnRH antagonist (detirelix) a dose of 100 ug/kg/day was necessary to completely abolish spermatogenesis. Unfortunately there was no description of the allergic side effects of this compound in this study. Recently, several pilot studies have been published in which a third generation antagonist was administered to dogs. The antagonist often used is acyline, this is a 10-amino acid peptide. This compound is more potent, of longer duration and with less side effects than other third generation antagonists. The side effects of acyline are limited to mild skin reactions like erythema, tenderness and bruising. These effects only take place at the site of injection. No systemic allergic side effect is provoked by acyline (Valiente et al., 2007). 
More research has to be done involving these GnRH antagonists because they remain very promising as male contraceptives (Valiente et al., 2007).       


1.3.2. GnRH agonist Deslorelin (Suprelorin®)

Chemical castration can be achieved by the GnRH agonist deslorelin like mentioned before. An implant is used containing the long acting and slow releasing GnRH agonist deslorelin (Suprelorin®, Peptech Animal Health, Sydney, Australia) (Trigg et al., 2006). Deslorelin is a superagonist. The potency is 40 to 144 times that of endogenous GnRH (Padula, 2005). 
Suprelorin® is a subcutaneous controlled release implant. It is implanted between the shoulders underneath the skin. Depending on the formulation used the duration of activity is around 6 or 12 months (Trigg et al., 2006). It is presented in the form of a pre-loaded applicator (EPAR, 2007).   
There are two versions of the deslorelin implant available. There is the 6 months formulation which is recently approved for sale in Europe. This implant contains 4,7 mg deslorelin (Suprelorin 6®; S6). And there is the longer acting 12 months formulation which is approved in Australia. This implant contains 9,4 mg deslorelin (Suprelorin 12®; S12). The S12 formulation is relatively unchanged from the S6 formulation. Only the carrier used for S12 is different. This will cause a slower release of deslorelin (Personal communication, Jeffrey de Gier, 2008).  
Suprelorin® is prescribed for the temporary sterilization of healthy, non-castrated, sexually mature male dogs (EPAR, 2007). The implant containing Suprelorin® releases a slow and constant low dosage of deslorelin (EPAR, 2007). 
S6 causes a decrease in plasma testosterone concentration, a decrease in testicular circumference, a decrease in libido and a decrease in spermatogenesis in male dogs. These effects start after 6 weeks in 95% of the dogs in a study of the European medicines agency (EPAR, 2007) and last for at least 6 months. After a chemical castration is exhausted the return to viable sperm counts, sperm volume and copulatory behaviour will take approximately 2,5 months (which is the duration of the normal spermatogenic cycle and epididymal maturation of spermatozoa) (Trigg et al., 2006).  
The site of implantation showed no significant inflammatory reactions to the implant, nor any systemic inflammatory reactions were described in a study of Trigg et al. (2006).  However, according to a study of the European medicines agency a minor swelling could be seen at the site of implantation and some local reactions (inflammation, hardening) could be seen during 3 months after implantation (EPAR, 2007). Furthermore, pregnant woman are not allowed to administer this product (EPAR, 2007). 
No adverse effects are reported for the use of S6. The drug is also safe in repeated dosages and can therefore be used for continuous periods of suppression of gonadal function in male dogs (Trigg et al., 2006). The effect of the deslorelin implant can be prolonged by repeated implantation (Trigg et al., 2006).
A lot of research has been done involving deslorelin in the male dog. A few of those studies will be discussed below, a review will be displayed in table 1 (attachment 1).          
 
In a study by Trigg et al. (2001) the mean plasma concentration of testosterone reduced to < 1 ng/ml within 6 to 25 days after implantation (6 mg and 12 mg deslorelin). The concentration remained at this level for a period ranging from 3.0 months to 2.7 years. After the period of downregulation all dogs resumed normal steroid genesis. Testicular volume restored, sperm characteristics associated with fertility returned and plasma concentrations of steroids increased to pre-implantation concentrations. Dogs that were used for mating after recovery were successful in achieving pregnancies. Duration of the effect is dose dependent (Trigg et al., 2001).  

In a study by Junaidi et al. (2003) 8 male dogs were used which were randomly organised into two groups: 4 dogs received a 6 mg deslorelin implant and 4 dogs received a blank implant which contained no drugs. These implants were injected subcutaneously between the shoulders. No significant changes in mean plasma concentration of LH and testosterone were seen in control dogs. The mean plasma concentration of LH increased rapidly within 20 minutes after implantation of the deslorelin implant (starting around 0,5-1,0 ng/ml). There was a peak of LH (± 4,5 ng/ml) after 40 minutes and a gradual decline until the concentration of LH did not differ from the control values anymore at 5 hours after implantation. The changes in the mean plasma concentration of testosterone were similar to that for LH. Within 40 minutes after implantation there was a stimulated secretion with a peak (± 7,8 ng/ml) after 1 hour. Normal values (comparable with control values) were reached after 5 hours (± 3-5 ng/ml). After this brief period of activation the mean plasma concentration of LH declined significantly below pre-treatment values by 9 days. This concentration remained below the limit of detection (< 0,06 ng/ml) from 3 weeks until week 49 after implantation. During week 50 there was a rapid increase of the LH concentration. It returned to normal pre-treatment values. Again, the changes of the mean plasma concentration of testosterone were similar to that for LH. There was a rapid decline of testosterone to undetectable values (limit of detection was 0,2 ± 0,1 ng/ml) within 3 weeks. It did not become detectable again for 44 weeks after implantation. The concentration of testosterone than began to increase approximately 6 weeks earlier than the concentration of LH. Normal values were reached at 52 weeks after implantation. Testicular volumes declined below control values by 5 weeks after implantation. A low and stable volume was established around week 10 and maintained for 40 to 45 weeks. In the largest part of the dogs the increase in testicular volume took place before the rise in testosterone concentration. There were no changes in testicular volumes seen in control dogs. Histological examination of tissues obtained after recovery of the deslorelin implant showed a normal appearance. Within 5 to 6 weeks after implantation with deslorelin sperm concentrations and motility both declined and the percentage of abnormalities increased. This caused complete infertility 6 weeks after implantation. Normal values were observed by week 60. No abnormal values were seen in the control group. The progressive decrease in ejaculate volume and motility and maturity of the ejaculated spermatozoa could be explained by the decreased plasma testosterone concentrations because testosterone normally controls prostate secretions and is necessary for the maintenance of spermatogenesis. Approximately 8 weeks after the recovery of testosterone concentrations normal sperm appeared in the ejaculate. So the effects of treatment with deslorelin seemed to be fully reversible. No adverse, long-term side-effects were observed during this study (Junaidi et al., 2003). 

In a subsequent study by Junaidi et al. (2007) the pituitary and testicular responses to exogenous GnRH and LH were studied in male dogs treated with the GnRH agonist deslorelin. For this study 20 mature male dogs were used. The dogs were randomly assigned in five groups of four animals each. One of these groups was a control group; these dogs received a blank implant. All of the dogs in the other groups (4) received a 6 mg deslorelin implant. No significant changes in mean plasma concentrations of LH and testosterone were seen in control dogs. The mean LH concentration increased rapidly within 20 minutes after the administration of the deslorelin implant. The concentration peaked at 40 minutes (± 3,8 ng/ml). After this peak the concentration began to decline and became very low by the second week after the implantation (0,06 ± 0,03 ng/ml). After this second week the concentration became undetectable (< 0,06 ng/ml) and remained undetectable during the study. Changes in mean plasma concentration of testosterone were similar to that for LH; there was an initial rise followed by a peak (± 5,5 ng/ml) and followed by a gradual decline. After 25 days following the implantation the testosterone secretion was almost completely suppressed. It became undetectable (limit of detection was 0,2 ± 0,1 ng/ml) after 30 days en remained this way during the study. 
After the i.v. administration of GnRH to the control group, peak LH concentrations (mean) were seen after 20 minutes and peak testosterone concentrations (mean) were seen a further 20 minutes later. After the i.v. administration of GnRH to dogs implanted with deslorelin the responses of LH and testosterone were significantly reduced on day 15 after implantation when compared to the control group. No responses of LH and testosterone were seen after the i.v. administration of GnRH on day 25 after implantation. Therefore, administration of a deslorelin implant resulted in a loss of pituitary responsiveness to GnRH. This was most likely the result of a downregulation of GnRH receptors on the gonadotrophs. The Leydig cells were also desensitized which was already seen 15 days after implantation. At this time the endogenous LH released by the injection of GnRH caused a smaller rise in testosterone than in the control group. 
The mean plasma concentration of testosterone increased in the control dogs after injection of bovine LH. This response was reduced in the dogs implanted with deslorelin. After day 40 no biological significant increase in plasma testosterone concentration could be caused by GnRH and LH (Junaidi et al., 2007). 

In a study by Schoemaker et al. (2008) the use of a deslorelin implant as an alternative for surgical castration in male ferrets was studied. There were 3 groups of animals: 1 received a deslorelin implant (9,4 mg deslorelin), 1 received a placebo implant and the animals of the other group were castrated surgically. The mean testosterone concentrations of the surgical and chemical castrated ferrets were significantly lower (< 0,05 nmol/L) than that of the placebo groups (9-73 nmol/L). There was no significant difference in mean testosterone concentration between the chemical and surgical castrated animals. The FSH concentration was lower in chemical castrated ferrets than in ferrets treated with a placebo implant. This concentration was higher in surgical castrated ferrets than in the ferrets with a placebo implant (Schoemaker et al., 2008).  


1.3.3. Other GnRH agonists

A lot of research has been done involving other GnRH agonists used in different animal species. A few of them will be discussed below, a review will be displayed in table 2 (attachment 2). Examples of the GnRH agonists used are: leuprolide, buserelin, nafarelin and triptorelin. 

In a study by Vickery et al. (1985) a subcutaneous injection of nafarelin acetate was administered to male beagle dogs once daily for 44 days. This resulted in a reduced basal plasma concentration of LH and testosterone. There was only a little effect on basal FSH production rates. The ejaculate volume, sperm count and sperm motility were also lowered by nafarelin. Because of the decreased concentration of LH and testosterone there was a decreased duration of ejaculation. Atrophic changes were seen in the epididymis and prostate. In this study 2 different dosages of Nafarelin (0,5 and 2,0 ug/kg) were used to reveal the dose-response relationship. This relationship was revealed by the time of maximal effect and not by the degree of effect. A higher dosage of Nafarelin will cause a more rapid suppression of reproductive function (Vickery et al., 1985).    

In a study by Inaba et al. (1996) 15 male beagle dogs received a sustained-release formulation of the GnRH agonist leuprolide acetate. The dogs received a single subcutaneous injection (0,1 or 1 mg/kg). The dosage of 1,0 mg/kg caused a decrease in ejaculatory volume and caused the disappearance of normal sperm cells within 8 weeks. This effect persisted for 6 weeks. Between week 8 and 14 after treatment the spermatozoa were not able to penetrate oocytes (in vitro test; canine oocytes obtained from mature Beagle bitches at random stages of the estrous cycle). The dosage of 0,1 mg/kg was not able to cause a suppression of spermatogenesis. All mentioned effects were reversible. The dosage of 1,0 mg/kg also caused a transient rise of mean plasma concentration of LH and testosterone. This rise was followed by a marked decline to levels below normal values. This low concentration was maintained for at least 5 weeks. The dosage of 0,1 mg/kg was not able to assert the same amount of suppression. No adverse side-effects were seen during this study (Inaba et al., 1996).  

In a study by Riesenbeck et al. (2002) 7 dogs were implanted with 6,6 mg of Buserelin. Within 15 days after implantation the plasma concentration of testosterone decreased to basal concentrations. This effect lasted for about 233 days. Semen could not be collected anymore from 21 days after implantation onwards. Testicular size was reversibly reduced (Riesenbeck et al., 2002).     






Surgical castration is a common way to control the behaviour of male dogs. Most dog owners choose surgical castration of their male dog in an attempt to change one or more objectionable behaviours (Hopkins et al., 1976). However, the effect of hormones on dog behaviour and the outcome of surgical castration are highly variable (Lindsay, 2001).
Male dogs are presented more frequently with behavioural problems than females. This is especially evident in the case of aggression. Male dogs can present this behaviour as much as 90% more often than females by some estimates. This suggests that there is a hormonal influence (male hormones) underlying the development of behavioural problems. Considering that surgical castration has a highly variable effect on behaviour of dogs, it is not exactly clear if there is a causal relationship between hormones and problem behaviour (Lindsay, 2001).
A lot of research have been done to investigate the effect of surgical castration in altering male behaviour. A few important questions can be asked: which behaviours are effected, what is the probability that a behaviour is altered by surgical castration in a specific individual, what is the role of experience in maintaining behaviour after surgical castration, does the age of the dog at the time of surgical castration play an important role, and are there other factors that play an important role in the outcome of surgical castration? 
Male sex-typical behaviour is the behaviour one would expect to be altered by castration. Examples of this behaviour are roaming, aggression, urine marking and sexual behaviour (including mounting) (Hopkins et al., 1976; Hart et al., 1997). The effect of surgical castration on these behaviours will be discussed below.






It could be concluded that testosterone has an important influence on roaming behaviour in male dogs following the major effect of surgical castration on this behaviour mentioned in literature.  
In a study by Hopkins et al. (1976) roaming reduced in 90% of the dogs. Most of the dogs used in this study (37 of 42) were castrated to control an unwanted behavioural problem, this could cause a biased observation by the owners in the direction of a placebo effect.
In a study by Idowu (1984) 15 of 17 dogs reduced their roaming behaviour after surgical castration, this was a reduction of 88,24% (Idowu, 1984). The results were comparable with the results of Hopkins et al. (1976).  
In a study by Neilson et al. (1997) the effect of surgical castration on roaming was also examined. In this experiment 57 male dogs were used between the age of 2 and 7 years old. Data was collected by telephone contacts with the dog owners. The study was predicted on the assumption that some dogs may have elimination of the problem behaviour, some dogs may have an improvement (at the 50% and 90% level) and some dogs may have no change of the problem behaviour after surgical castration. Roaming showed an improvement of 25 to 40% at the 90% level and an improvement of 60 to 80% at the 50% level. So results of this study indicated that for 50 to 70% of adult male dogs a decrease between 50 and 90% in roaming could be expected after surgical castration.  
This rather uniform effect of surgical castration on roaming behaviour could perhaps be explained by the fact that roaming is a sexually motivated behaviour. Surgical castration will lead to a major reduction in sexual motivation, which could result in a major reduction in roaming (Hart et al., 1997).

Some dogs show only a little decline in roaming behaviour after surgical castration. In a study by Maarschalkerweerd et al. (1997) the behaviour was split up in two different motivations: induced by bitches in heat and other causes. One hundred and twenty four dogs were used, their owners were interviewed by telephone. The dogs were castrated between 6 and 12 months before the interview. In 64% of the dogs a decline was seen when the behaviour was induced by bitches in heat. Only 16% of the dogs showed a decline in roaming behaviour when there was no sexual stimulus (Maarschalkerweerd et al., 1997). 
The effect of surgical castration on roaming will therefore dependent on the motivation behind this behaviour. If it is caused by a bitch in heat a great reduction in behaviour can be expected. If the behaviour is caused by different causes the result will probably be of little satisfaction. 

   
1.4.2.2. Aggression 

Aggression by dogs is a major complaint by dog owners (Beaver, 1983). It is an extreme complex behaviour which is influenced by physiological, environmental, social and genetic factors (Trainor et al., 2006). During aggressive behaviour hypothalamic and limbic regions of the brain are activated (Trainor et al., 2006). 
This behaviour deserves some special consideration. It is not a fixed term; aggression on its own is not specific enough. It is important to determine which type of aggression plays a role (Beaver, 1983).  

There are eight different types of aggression, including: competitive aggression, fear-induced aggression, pain-induced aggression, maternal aggression, predatory aggression, territorial aggression, learned aggression and aggression toward other male dogs (inter-male aggression) (Hart, 1974; Hopkins et al., 1976).
The term competitive aggression is another term for dominance aggression (Beaver, 1983). For example, this type of aggression is used when two dogs fight over a limited amount of highly flavoured food or desirable rest areas. This behaviour occurs in females and in males (Hart, 1974). Fear-induced aggression is shown equally by male and female dogs. There is no evidence that surgical castration can alter this behaviour. The dog will use this type of aggression in situations where it would escape when possible. A dog (females and males) will attack if painfully stimulated. This kind of aggression is called pain-induced aggression. Predatory aggression is different from other types of aggression because this behaviour does not involve growling, visual displays or threats. Female and male dogs can use territorial aggression if strange dogs (or strange people) enter their immediate territory. Dogs can also be trained to attack on command, this is the case with learned aggression. A typical sexual dimorphic behaviour is inter-male aggression. Male dogs appear to have an innate desire to fight with other male dogs. Females do not show this behaviour with regard to each other. The behaviour seems to be related to testosterone production. There are reports of surgical castration altering this behaviour, but this result is very variable amongst different individuals (Hart, 1974).     

There is evidence to suggest a relationship between androgens and aggressiveness. Seasonal variation in plasma testosterone concentrations coincides with seasonal variation in aggressiveness in rodents, primates and birds. Aggressiveness is seen for the first time in mice when the plasma concentration of testosterone is rising at the beginning of puberty. Some researchers found a correlation between baseline testosterone concentrations and level of aggression in mice and monkeys. However, the effect of testosterone on the brain in relation to aggression is more pronounced in rodents than in monkeys (Knol et al., 1989). 
Furthermore, since male dogs exhibit aggression more often than females one could expect some hormonal influence in the aetiology of aggressive behaviour. One could expect to see increased signs of aggression in dogs between 6 en 8 months of age if testosterone plays an important role in the expression of this behaviour. It is at this particular age that male dogs undergo an endogenous surge of androgen activity. Male dogs do appear to go through a period of behavioural transmission, but this period is not significantly characterized by an expression of extreme aggression. Although some dogs can become more aggressive toward other male dogs during this period (Lindsay, 2001).

From literature it does not become exactly clear which type of aggression can be affected by surgical castration. The results of the different studies can be very conflicting. 
In a study by Hopkins et al. (1976) only aggression toward other male dogs was altered by surgical castration. In this study aggressive behaviour toward other male dogs declined in 62% of the dogs. There was no reduction when the aggression is territorial or fear-induced (Hopkins, 1976). Voith (1980) also mentioned that surgical castration is an effective approach to deal with inter-male aggression (Voith, 1980). 
According to Lindsay (2001) few dogs exhibited a significant improvement after surgical castration when it comes to inter-male fighting. Although it seemed as if the tendency to fight was modulated to some extent by surgical castration. It could be that castrated male dogs were less attractive as opponents for intact male dogs (Lindsay, 2001). 
In a study by Neilson et al. (1997) approximately 25% of dogs had a 50 to 90% level of improvement after removal of the testis when it comes to aggression toward other canine or human members of the family. With regard to aggression toward unfamiliar dogs or human territorial intruders 10 to 15% of the dogs had a 50 to 90% level of improvement after surgical castration (Neilson, 1997). 
In the previously mentioned study by Maarschalkerweerd et al. (1997) aggressive behaviour was split up in the following categories: outside, inside, to unfamiliar people, to familiar people, inter-male aggression, to bitches and other objects. Aggressive behaviour inside of the house decreased in 26% of the castrated dogs and outside of the house in 52% of the dogs. Aggressive behaviour toward unfamiliar people showed a decrease in 22% of the dogs, toward familiar people in 9% of the dogs and toward bitches in 26%. Aggressive behaviour toward other male dogs outside the house showed a decline in 57% of the dogs. No change was seen in aggression toward other objects after surgical castration. An increase in aggressive behaviour toward known people (4%), strangers (4%) and other dogs (4%) was seen in a few dogs (Maarschalkerweerd et al., 1997). 
In a study by Idowu (1984) a rapid decline of inter-male aggression was seen in 14,29% and a gradual decline in 38,09% of the male dogs after surgical castration (Idowu, 1984).
Competitive or dominance aggression only showed a little reduction in the study of Neilson et al. (1997) (aggression toward other canine or human members of the family) and in the study of Maarschalkerweerd et al. (1997). Fear-induced aggression was only mentioned in the study of Hopkins et al. (1976) and showed no change after surgical castration. Pain-induced, predatory aggression and learned aggression were not mentioned in these studies. Territorial aggression showed no reduction after surgical castration according to Hopkins et al. (1976) and a little reduction according to Neilson et al. (1997). Inter-male aggression  showed a fair decline after surgical castration (62%) according to Hopkins et al. (1976) and according to Voith (1980). According to Lindsay (2001) the effect of surgical castration on inter-male aggression was only minimal. Maarschalkerweerd et al. (1997) mentioned a decline of 57% when it comes to inter-male aggression. Therefore, according to the mentioned literature inter-male aggression is the only type of aggression of which a noteworthy decline after castration could be seen. However, this is not an uniform result of castration. The other types of aggression show no change or just a minor change after castration according to this literature.  

According to Lindsay (2001) testosterone enhances selective attention in the direction of a target and decreases distraction to external stimuli at the same time. It is very difficult to disrupt the selective attention once it is frozen on the target. That is why it is very important to capture the dog’s attention at the beginning of aggressive arousal. Surgical castration can decrease the dog’s ability to focus fully on a target. Thereby making it easier to divert the agonistic intentions. 
So, although surgical castration can not eliminate aggression in most cases, it can make aggression problems more responsive to other management solutions (Lindsay, 2001).  

Comparable research is done involving ferrets. In a study by Vinke et al. (2008) the effect of castration on the behaviour of male ferrets was investigated. Furthermore, the behavioural effect of surgical castration was compared with the behavioural effect of chemical castration using the GnRH agonist deslorelin. Surgical or chemical castration of male ferrets resulted in a minor decrease of aggressive behaviour between male ferrets. A chemical castration with the GnRH agonist deslorelin had surprisingly more effect on the reduction of aggression than a surgical castration. The finding that surgical castration barely had an effect on aggression was surprising since reduction of aggression is the major motivation for surgical castration of ferrets. A decrease of testosterone concentrations to near-zero was found in both the surgically and chemically castrated group. This major decrease of testosterone though was in itself not enough to reduce aggression in ferrets (Vinke et al., 2008). 

  
	1.4.2.3. Urine marking 

Urine marking is a sexual dimorphic behaviour. A different posture is taking on during urination by females and males. Marking of specific environmental targets is more likely done by male dogs than by female dogs. Furthermore, the frequency of urination is higher for males (Beach, 1974).
If male dogs are castrated at birth they never exhibit normal maturation of urinary behaviour, especially not the male typical posture. They alternate between immature and mature patterns of urination when adulthood is reached (Beach, 1974). 
If male dogs are castrated neonatally they begin to exhibit the masculine urinary posture at a later age than at the normal age of puberty. These developmental changes are therefore not dependent upon normal rise in testosterone secretion during puberty (Beach, 1974).  
Scent marking is an important aspect of territorial and social behaviour in animals. Urine marking of male dogs can generally be referred to as scent marking. In a strange area urine marking occurs in a high frequency compared to a low frequency in the home area (Hart, 1974). 
This marking behaviour is androgen dependent in some species of animals. For example, a decline in marking behaviour after castration is seen within 2 to 4 weeks in hamsters en gerbils (Hart, 1974).  

In a study by Hart (1974) a comparison of the effects of surgical castration on sexual behaviour with the effect of surgical castration on urine marking in the same male dogs was made. In a period of five months the mean mating frequency declined from 100% before surgical castration to 58% after castration. Within this same period there were no quantitative changes in urine marking seen in male dogs. This could indicate that there is a difference in the degree of androgen influence on scent marking (urine marking in dogs) when the dog is compared to other mammals like hamsters and gerbils (Hart, 1974).   
In the study by Hopkins et al. (1976) urine marking in the house declined in 50% of the dogs. In these cases the urine marking outside the house was not affected (Hopkins et al., 1976). 
According to Neilson et al. (1997) urine marking showed a decline of 25 to 40% at the 90% improvement level and a decline of 60 to 80% at the 50% improvement level. So results of this study indicated that for 50 to 70% of adult male dogs decreases between 50 and 90% in urine marking could be expected after surgical castration (Neilson et al., 1997).  
Urine marking inside the house decreased in 69% of the dogs and outside the house in 23% of the dogs in the study by Maarschalkerweerd et al. (1997). Six out of 124 dogs changed the typical male urination position for that of the bitch (Maarschalkerweerd et al., 1997).
Therefore, the effect of surgical castration on urine marking behaviour can be very diverse following literature.  


1.4.2.4. Sexual behaviour (including mounting) 

Sexual behaviour, including mounting, intromission of the penis and ejaculation, is expected to be affected the most by gonadectomy (Hart, 1997). Surgical castration of adult male dogs leads to a declined sexual responsiveness to oestrus females (Boeuf, 1970). After surgical castration ejaculation is the behaviour first lost. In some male dogs followed by the loss of mounting and interest in bitches (Hart, 1997). However, there are individuals that continue to mate and show sexual behaviour for years after the surgical castration (Boeuf, 1970). Copulatory activity can be retained for several months or years. Fifteen weeks after surgical castration 80% of the dogs still showed copulatory behaviour in a study by Hart (1974). There is however a great deal of individual variability (Hart, 1968). Male dogs that show a great persistence in sexual activity after surgical castration do show a reduced motivation (Hart, 1968). And even though dogs can show sexual behaviour for extended periods, there will be a prompt reduction in the responsiveness of the male dog to a receptive female. Sexual behaviour will eventually vanish (Hart, 1974).  
Puppies can go through a period of mounting people, dogs or objects. This behaviour often ceases when they mature (Hart, 1976). 
The degree of retention of sexual behaviour also varies greatly among species (Bloch et al., 1967). Dogs retain the ability to copulate for longer periods of time than do guinea pigs, rats or hamsters after gonadectomy (Beach, 1970). Sexual behaviour persists for several weeks after removal of the testis in the guinea pig (Resko, 1970). This behaviour almost completely disappears immediately in castrated horses, only a few of these animals will continue to show copulatory behaviour (Knol et al., 1989). 
  
In the previously mentioned study by Maarschalkerweerd et al. (1997) hypersexual behaviour toward people decreased in 57% of the dogs after surgical castration. A decrease of sexual interest in other dogs was seen in 40% of the castrated dogs. The data used was achieved by telephone interviews with the dogs owners. The dogs were castrated in a period between 6 and 12 months before the interviews. Nothing was known about the age of the dogs or about possible successful mounts before surgical castration (Maarschalkerweerd et al., 1997).
Mounting of animals and people declined in 67% of the dogs in the study of Hopkins et al. (1976). The number of rapid or gradual declines was divided equally. The age of the dogs used for this study was between 8 months and 12 years. It was unknown if the dogs had mounted successfully before the surgical castration. The data for this study was achieved by telephone interviews with the dogs owners. These were conducted with a mean of 27 months from the date of surgical castration (Hopkins et al., 1976). 
According to Neilson et al. (1997) mounting showed a decline of 25 to 40% at the 90% improvement level and a decline of 60 to 80% at the 50% improvement level. So results of this study indicated that for 50 to 70% of adult male dogs decreases between 50 and 90% in urine marking could be expected after surgical castration. The dogs used were between 2 and 7 years old. The data was collected by telephone interviews with the dogs owners. Nothing was known about the time span between surgical castration and the interviews (Neilson et al., 1997).
In these studies a moderate decline in sexual behaviour is shown while earlier is mentioned that sexual behaviour will vanish eventually. The time span between surgical castration and data collection could be to short to notice a greater reduction. 

All elements of copulatory behaviour can survive for years after surgical castration of male dogs. In an experiment by Beach (1970) mounting and thrusting showed no decline after removal of the testis. However, other elements of the coital behaviour (intromission of the penis, rapid thrusting and locking) did deteriorate after surgical castration within 6 months. The number of intromission movements decreased, the duration of rapid thrusting shortened, there was a drop in the percentage of tests with locking and the average duration of locks was shortened. After this first reduction no further reduction of these behaviours was seen during the next 1 to 5 years. A few dogs were injected with testosterone propionate. They showed an increase in duration of rapid thrusting, an increased percentage of tests with locks and a prolongation of lock duration. So it appeared that these alterations were due to androgen deficiency (Beach, 1970).
In a study by Hart (1968) there was one significant observation regarding the alteration of specific sexual responses following surgical castration; a reduction in the duration of the copulatory lock. In this experiment no change in rapid thrusting behaviour was observed after surgical castration in contrast to the results of Beach (1970) (Hart, 1968).
 
Since some dogs show sexual behaviour after surgical castration, the mechanisms which are capable of mediating this behaviour are independent of testis hormones for their function in male dogs (testosterone is metabolised in a few hours) (Beach, 1970). However, some elements of sexual behaviour are restored after testosterone replacement therapy following surgical castration indicating some sort of androgen influence. Furthermore, the behaviour will eventually disappear after surgical castration also indicating an androgen influence. Still, it is not clear yet how it is possible that the sexual behaviour can survive for such prolonged periods of time after surgical castration.        


1.4.2.5. Other behaviours  

Except the mentioned behaviours other behaviours can be affected by  surgical castration. 

Some dogs become calmer and more affectionate after surgical castration (Hopkins et al., 1976). According to Maarschalkerweerd et al. (1991) 36% of the dogs became less active.  Hyperactivity showed no change after surgical castration according to Hart (1976).
Maarschalkerweerd (1997) mentioned that 6% of the male dogs became attractive to intact males after surgical castration (Maarschalkerweerd et al., 1997). 
Approximately 42% of surgically castrated dogs show an increase in appetite and will eventually gain weight after surgical castration. Testosterone is a anabolic steroid and will therefore stimulate the protein metabolism. Following surgical castration less nutrients will be metabolised in protein but in return will be metabolised in fat. Testosterone also has a direct influence on the food intake. The neural suppression on food intake disappears when the plasma concentration of testosterone drops after surgical castration: the dog will eat more and will gain weight (Maarschalkerweerd et al., 1991).









Dogs included in the pilot study were adult males of different breeds. There were no inclusion criteria for this study. For this pilot study 21 dogs were used; 17 dogs with a complete set of information, 4 with an incomplete set of information. The age of the dogs was between 8 months and 5 years. These dogs were treated with a GnRH implant containing 4,7 mg or 9,4 mg of deslorelin (S6 or S12) according to the owners preference; 8 dogs received S6 and 13 dogs S12. The dogs were patients of the Faculty of Veterinary Medicine, Utrecht University. The dogs were presented to the clinic from March 2006 until July 2008 for treatment of behavioural problems or just for the implantation of Suprelorin® which was not on general sale at that time. The duration of problem behaviours prior to treatment was not known. This study is followed by a prospective larger scale study.
















Hormone assays: A GnRH-stimulation test will be done twice to understand the hormonal changes: shortly before and 5 months after treatment. GnRH (Receptal®; 0.1 ml/kg) will be administered intravenously at T=0. Blood will be collected in a heparin tube at T= -40 (minutes), T=0 (before the administration of GnRH), T=10, T=60 and T=90. Measurement of LH and FSH will be done in the blood samples collected at T=-40, T=0, T=10 and T=60. Measurement of Testosterone will be done in the blood samples collected at T=0, T=60 and T=90. For the measurement of LH and FSH 4 ml of blood will be collected. For the measurement of LH, FSH and testosterone 8 ml of blood and for testosterone alone 4 ml of blood will be collected.
2.2.2.2. Behavioural data

Questionnaire: Different aspects of the dogs behaviour will be questioned. The owner of the dog will receive this questionnaire by email or by post on two different moments: shortly before treatment and 5 months after treatment. Furthermore, at 4 different moments (1, 3, 5 and 7 weeks after treatment) the owners will undergo a telephonic follow-up questionnaire to inquire the observed behavioural changes (attachment 4). During this phone call the owner will be asked 18 different questions about their dog: 10 questions about different behaviours (increase, decrease, even or it does not apply to the dog (N/A)), 6 questions about physical features (yes/no; increase, decrease, even or N/A) and 2 questions in general.     
    
Behavioural test: This behavioural test will be done to get an objective picture of the dogs behaviour. The test will be done twice to look at possible behavioural changes: shortly before and 5 months after treatment. This test was composed for the use in this study. The behaviour will be observed in a neutral environment for the dog (veterinary hospital clinic). The behaviour test consists of 13 different tests: 
1.	Approach and greeting of friendly strange person 
2.	Exploring new space 
3.	Walking the dog (with leash) outside and inside
4.	Basic commands (sit, down, come)
5.	Stroking the dogs back by the owner
6.	Keeping the dog on its back by the owner (restraint dominance)
7.	Playing with a floss 
8.	Owner down on the floor
9.	Response to doll
10.	Staring at the dog by owner and stranger
11.	Response to umbrella (visual stimulus)
12.	Response to rattle (acoustic stimulus)
13.	Meeting a strange bitch in heat (doll)


2.3. Data used in this paper







3.1. Results of pilot study

All data collected in the pilot study are summed up in table 3 (attachment 5). The information of table 3 is summarized in tables 4 and 5 (attachments 6 and 7, respectively). The most important changes will be discussed here and are displayed graphically in figures 3-9. 

A behavioural change after implantation was obvious for 17 out of 21 dogs. This change was only minor for 2 dogs, was absent for 1 dog and was unknown for 1 dog (table 4). 




























Play behaviour increased in 6 out of 21 dogs after implantation, for 2 out of 21 dogs this was unknown. The dog became calmer in 5 out of 21 dogs, for 2 out of 21 dogs this information was unknown. In 6 out of 21 dogs the dogs response to commands became better after chemical castration, for 2 out of 21 dogs this was unknown (table 5). Of the dogs with a chemical castration 6 were eventually castrated surgically, for 3 out of 21 dogs this information was unknown. The results of this surgical castration were comparable with the results of the chemical castration in 4 dogs, for 1 dog this was unknown. For the other dog the behavioural effect of the surgical castration was better than the effect of the chemical castration; the behavioural changes were comparable but were more obvious after surgical castration (table 4).

A reduction of testis circumference was seen in 18 out of 21 dogs, for 2 dogs this was unknown. Only 1 dog showed no reduction in circumference, however, this dog did show a behavioural change after chemical castration (table 4). A complete reduction of preputial infection was seen in 5 out of 21 dogs, for the other 16 dogs this information was unknown (table 5).














3.2  Results of the prospective study: telephonic follow-up questionnaires 

The results of the telephonic follow-up questionnaires are displayed in 4 tables (table 6, 7, 8 and 9), according to the interval from treatment to moment of contact (1, 3, 5 or 7 weeks after treatment;  attachment 8). The most important changes will be discussed here and are displayed in figures 10-16.

All of the 6 dogs of the telephonic follow-up showed behavioural changes after chemical castration (table 6, 7, 8 and 9). 







The changes in sexual behaviour after implantation are displayed in figure 11. There seemed to be a general decline of this behaviour. Dogs with a minor or major increase (2 out of 6) were only seen in the 1st week. After this period increase of sexual behaviour was not seen anymore. The behaviour had already disappeared completely in 2 out of 6 dogs in the 3rd week and in 3 out of 6 dogs in the 7th week. 






















































4.1. Pilot study and telephonic follow-up of the prospective study 

The majority of dogs that were included in the pilot study showed major behavioural changes after chemical castration. The onset of behavioural changes seemed to be almost identical for both the S6 and S12 implant group. It started between 3 and 6 weeks after implantation for the majority of dogs. A behavioural change was also seen in all of the dogs of the telephonic follow-up. These changes became obvious after approximately 3 weeks following treatment with deslorelin. Little is know about the onset of behavioural changes in literature. In the studies regarding chemical castration the onset of a reduction in plasma testosterone concentration was of particular interest. In a study by Trigg et al. (2001) this concentration reduced to < 1ng/ml within 6 to 25 days (approximately 1-3 weeks) after implantation of 6 mg and 12 mg deslorelin in male dogs. The time necessary to reach lower levels of testosterone was unknown. In a study by Junaidi et al. (2003) the plasma concentration of testosterone reduced to undetectable values (<0,2 ng/ml) within 3 weeks after the implantation of 6 mg deslorelin in male dogs. In a subsequent study of Junaidi et al. (2007) this concentration reached undetectable values (<0,2 ng/ml) after 30 days (approximately 4 weeks) following implantation of 6 mg deslorelin in male dogs. So the onset of testosterone reduction and the onset of behavioural changes appear to be situated in the same period of time, although the onset of testosterone reduction seems to be prior to the onset of behavioural changes. According to the study by Trigg et al. (2001) the onset of testosterone reduction did not depend on the dosages of deslorelin used. The reduction of the plasma concentration of testosterone could therefore be associated with the onset of behavioural changes after chemical castration. In literature concerning surgical castration the onset of behavioural changes is only mentioned regarding sexual behaviour. Male dogs can show sexual behaviour for months or years after surgical castration before a change in this behaviour can be observed (Boeuf, 1970; Hart, 1974). Because testosterone is metabolized within a few hours after surgical castration (Post, 1982) it can not be associated with the late onset of this reduction in sexual behaviour in male dogs after surgical castration. So after surgical castration testosterone is metabolized within a few hours in contrast with chemical castration at which the testosterone concentration takes a few weeks to disappear (Post, 1982; Junaidi et al., 2003; Junaidi et al., 2007). If the reduction of testosterone concentration is associated with the onset of behavioural changes, it could be possible that the behavioural changes after surgical castration will occur before the behavioural changes after chemical castration. 
For the majority of dogs with an S6 implant the pre-treatment behaviour returned between 5 and 7 months after implantation. There were, however, a couple of dogs at which the S6 implant was still active after 10 months. There was even 1 dog with an activity of 24 months. For the majority of dogs with an S12 implant the implant was still active at the time of the questionnaire. The implant was still active after 10 months in the majority of these dogs. For the remaining dogs the pre-treatment behaviour returned after 6-12 months. The behavioural changes can therefore last for a variable period of time after the use of S6 and S12. According to Trigg et al. (2006) the duration of activity was around 6 or 12 months depending on the formulation used (S6 or S12, respectively), meaning that at this time the plasma concentration of testosterone will rise again because the antagonistic actions have stopped. This would mean that the activity regarding testosterone reduction is not very similar to the activity regarding behavioural changes.  Unfortunately there are no endocrinological data available for the dogs in the pilot study, so there is no information about the plasma concentrations of testosterone. The variation in duration of activity when it comes to behavioural changes after the use of S6 and S12 can be explained in 2 ways. There is no correlation between the testosterone reduction and the behavioural changes: the return to pre-treatment behaviour will be independent of the rise in testosterone concentration after 6 or 12 months (S6 or S12 respectively). There is a correlation between the testosterone reduction and the behavioural changes meaning that the increase in testosterone concentration can occur after a variable period of time following the use of S6 or S12. In both cases it could cause a great deal of trouble when S12 is approved for sale in Europe because there might be no guarantees that the more expensive S12 will have a longer duration of activity when it comes to behavioural changes (maybe even when it comes to testosterone reduction) than S6. 

Roaming behaviour did not apply to the majority of dogs of the pilot study or was unknown because of incomplete questionnaires. The remaining dogs showed a (complete) reduction of this behaviour. Roaming behaviour also did not apply to the majority of dogs of the telephonic follow-up. The remaining dogs showed a (complete) reduction after chemical castration just like the dogs of the pilot study. In both studies nothing was known about the motivation of roaming behaviour. This motivation is important for the result of a surgical castration; a noteworthy decline can only be seen after surgical castration if there is a sexual motivation (Maarschalkerweerd et al., 1997). Because roaming decreased after chemical castration in the dogs which showed this behaviour prior to castration a sexual motivation could be possible. After a surgical castration roaming will stay the same or decrease, it will never increase (Hopkins et al., 1976; Idowu, 1984; Neilson et al., 1997; Maarschalkerweerd et al., 1997). An increase of roaming after chemical castration was also never seen. 

Aggression towards people also did not apply to the majority of dogs of the pilot study. However, in the S6 group there were 3 out of 8 dogs that showed a decrease of this behaviour after chemical castration. A minor decrease in aggression towards people was also seen in a study by Maarschalkerweerd et al. (1997) after surgical castration. Aggression towards people did not apply to the dogs of the telephonic follow-up study. 
In the majority of the dogs of the pilot study inter-male aggression decreased after chemical castration or did not apply. This decrease was most obvious in the S6 group, in the S12 group the majority of dogs did not show the behaviour in the first place. The response to chemical castration of male dogs was not very uniform when it comes to inter-male aggression in the telephonic follow-up study. Maybe a more uniform response could have been seen if the interval between treatment and questionnaires would have been longer. In general, the behaviour seemed to decline. A noteworthy decline of aggression after surgical castration can only be seen when it comes to inter-male aggression (Maarschalkerweerd et al., 1997; Lindsay, 2001). This inter-male aggression is a sexual dimorphic behaviour, females do not show this behaviour towards each other (Hart, 1974). Therefore, testosterone seems to be important for this behaviour to occur and castration should cause an abolishment of this behaviour. The results of a chemical castration are however very diverse amongst different individuals. The results of a surgical castration are also very diverse (Hart, 1974). So testosterone does not appear to be the only factor in the occurrence of inter-male aggression, something else must be of influence. The results of surgical and chemical castration appear to be comparable regarding inter-male aggression. 
Aggression toward bitches did not apply to the majority of dogs of the pilot study and did not apply to the dogs of the telephonic follow-up study. 
 
In the majority of dogs urine marking stayed the same or decreased after chemical castration in the pilot study. The decrease was most obvious in the S6 group. This behaviour stayed the same for the majority of dogs of the telephonic follow-up study. Maybe the interval between treatment and questionnaires was to short to notice a more distinct change in both studies.  Urine marking is also a sexual dimorphic behaviour. The frequency of urination is higher for males (Beach, 1974). Therefore, testosterone seems to be important for the occurrence of this high frequency. However, sometimes a decline of urine marking is never seen after chemical castration. The effect of a surgical castration on urine marking is also very diverse (Hopkins et al., 1976; Neilson et al., 1997, Maarschalkerweerd et al., 1997). 

Every dog which showed sexual behaviour before chemical castration showed a decrease or a complete reduction of this behaviour after chemical castration in the pilot study. The complete reduction of this behaviour was most obvious in the S6 group. In the majority of dogs, which showed sexual behaviour before chemical castration, this behaviour also disappeared completely after treatment in the telephonic follow-up study. Only in the 1st week an increase of sexual behaviour could be seen: 2 out of 6 dogs showed an increase of sexual behaviour in this study. This increase could be the result of the initial stimulatory effect of treatment with a GnRH agonist (Inaba et al., 1996; Junaidi et al., 2003; Gobello, 2006). A moderate decline could be seen after surgical castration according to Hopkins et al. (1976), Neilson et al., (1997) and Maarschalkerweerd et al., (1997). In none of these studies a complete reduction of sexual behaviour was mentioned. The time span between surgical castration and questionnaires was between 6 and 12 months in the study by Maarschalkerweerd et al. (1997), this interval had a mean of 27 months in the study by Hopkins et al. (1976) and was unknown for the study by Neilson et al. (1997). This interval could be to short to notice a complete reduction of sexual behaviour since dogs can show this behaviour for months or years after surgical castration (Hart, 1974). According to these results the effect of chemical castration on sexual behaviour appears to occur sooner than the effect of surgical castration on sexual behaviour. Puppies can go through a period of mounting people, dogs or objects. This behaviour will cease when they mature (Hart, 1976). The ceasing of this behaviour could be mistaken for the effect of chemical castration on the complete reduction of sexual behaviour. However, the dogs used in the pilot study and in the telephonic follow-up study had all passed this age at the time of treatment. Nothing was known about the age of the dogs used in the study by Maarschalkerweerd et al. (1997). The dogs of the study by Hopkins et al. (1976) were between 8 months and 12 years old and the dogs of the study by Neilson et al. (1997) were between 2 and 7 years old. Since none of these dogs showed a complete reduction of sexual behaviour a possible intervention of the puppy behaviour is not important for these dogs. 

A portion of the dogs of the pilot study showed an increase in play behaviour. Play behaviour also appeared to increase after implantation in the telephonic follow-up study; the majority of dogs showed a major increase of this behaviour after chemical castration. The increase in play behaviour can be explained by the lowered testosterone levels after chemical castration (Vinke et al., 2008). 

A portion of the dogs of the pilot study became calmer after chemical castration. On the other hand, the majority of dogs of the telephonic follow-up study showed an increase in general agility after chemical castration. However, this increase did not appear to be a general response to implantation; some dogs showed a minor decrease. According to these results dogs can become calmer or more active (increased general agility) after a chemical castration. According to Hopkins et al., (1976) some dogs also became calmer after surgical castration. According to Maarschalkerweerd et al. (1991) 36% of the dogs became less active after surgical castration. Both after chemical and surgical castration the result of castration is not very uniform when it comes to the activity of the dog. 

A portion of the dogs responded better to commands after chemical castration in the pilot study. In the telephonic follow-up study the dogs did not show an uniform effect regarding their responses to commands after chemical castration: this behaviour stayed the same, showed an increase or a minor decrease.

A few dogs of the pilot study were eventually castrated surgically, with comparable results between the behavioural changes after chemical castration and surgical castration. In one cases the behavioural changes after surgical castration were more obvious than after chemical castration. It could be possible that this dog was castrated surgically when the deslorelin implant was still active. In that case, the behavioural changes caused by the deslorelin implant would not have been at it’s maximum at the time of the surgical castration. After the surgical castration the dog’s behaviour could change even more through which it could seem as if the behavioural changes were more obvious after surgical castration. However, the owner of this dog mentioned that the behavioural changes caused by the chemical castration ended after 5,5 months while the dog was only castrated surgically after 6 months.

The majority of dogs showed a reduction of testis circumference in the pilot study. Only 1 dog showed no reduction. There is a correlation between testosterone and testis volume in male dogs: a decline of testosterone is followed by a decrease in testicular size after the use of a GnRH agonist (Vickery et al., 1985). Since the reduction of testosterone could be associated with behavioural changes after chemical castration, there could also be a correlation between behavioural changes and testis volume. If this were the case the dog without a reduction of testis circumference should not have shown behavioural changes after chemical castration. However, this dog did show a behavioural change. Though, the owner of this particular dog gave contradictory answers concerning the dogs behaviour and physiology, as a result the answers were not very trustworthy. On the other hand, in the dog of the pilot study without a behavioural change there was a reduction of testis circumference. This reduction of testis circumference could be correlated with a reduction of testosterone, while the reduction of testosterone was not correlated with behavioural changes in this dog. A reduction in testis circumference was seen in 100% of the dogs of the telephonic follow-up study.  

A complete reduction of preputial infection was only seen in 5 out of 21 dogs in the pilot study. However, for the remaining dogs nothing was known about preputial infection. The questionnaire did not contain a question about preputial infection. The retrieval of this information depended entirely on the information of the owner. This should have been done differently so that a better picture of this infection could have been formed. A major increase of preputial infection was seen in 1 dog in the 1st week after implantation in the telephonic follow-up study. This might be caused by the initial stimulatory effect of a GnRH agonist implant (Inaba et al., 1996; Junaidi et al., 2003; Gobello, 2006). After 5 weeks the infection was completely gone in 100% of the dogs which suffered from preputial infection before treatment in the telephonic follow-up study. A complete reduction in 100% of the affected dogs could perhaps have been seen in the pilot study if more information was known regarding preputial infection. 
In the majority of dogs of the pilot study no direct relationship (difference less than 1 week) was seen between the onset of behavioural change and reduction of testis circumference. In the S6 group it seemed as if the testis reduction took place before the behavioural changes, in the S12 group this was highly variable. If there would be no correlation between behavioural changes and testis circumference, a correlation between behavioural changes and testosterone reduction would not be very likely either.  

The appetite showed a general increase after chemical castration in the telephonic follow-up study; in the 7th week the majority of dogs showed a major increase. After surgical castration approximately 42% of the dogs showed an increase in appetite according to Maarschalkerweerd et al. (1991). The reduction of testosterone concentration caused the disappearance of the neural suppression on food intake (Maarschalkerweerd et al., 1991). This neural suppression on food intake could also disappear after chemical castration since the plasma concentration of testosterone also decreases. 


4.2. Influence of experience  

Because of the individual differences in response to chemical and surgical castration it can be possible that there is a link between experience and the loss of this specific behaviour (Hart et al., 1997). 

In literature mainly the role of experience in maintaining sexual behaviour after surgical castration is examined. The role of experience in maintaining other problem behaviours is much less described. An exception is a study by Neilson et al. (1997) where no relationship was found between duration of the problem behaviour prior to surgical castration (roaming, urine marking, aggression and mounting) and effects of surgical castration (Neilson, 1997). 
In a study by Hart (1968) the role of prior experience in the effects of surgical castration on sexual behaviour of male dogs was examined. Two groups were formed: dogs that were allowed 30-40 complete matings including a copulatory lock before surgical castration (experienced group), dogs that were allowed to investigate and mount an estrous bitch but were not allowed to copulate (inexperienced group). In this experiment a mating was defined as a copulation which included a copulatory lock. The tests (starting one week after surgical castration and continued for one year) showed no differences in sexual behaviour between the two groups. Experience in performing copulatory behaviour appeared to have no predictive ability as to whether the male dog will change it’s behaviour or not. However, a real control groups was missing in this study; there were no male dogs without any contact with an estrous bitch before surgical castration. If such a group was included the results might have been different (Hart, 1968).   
A similar study was done involving male cats. Experienced male cats exhibited a more prolonged retention of sexual behaviour than inexperienced male cats. Intromission of the penis could be achieved for 10 weeks after surgical castration by experienced cats whereas none of the inexperienced cats could achieve this after the first week following surgical castration (Rosenblatt et al., 1958). 
In a study by Bloch (1968) the effects of experience on sexual behaviour after surgical castration were examined in the male rat. The results were comparable with the results of similar experiments conducted with dogs. There was no difference in mating behaviour after surgical castration between rats which had no experience before surgical castration compared with other rats which had a considerable amount of experience (Bloch, 1968). 

Therefore, experience does not seem to play a role in the different responses to surgical castration. However, there is a difference between different species of animals. Of the 21 dogs in the pilot study there were only 2 dogs with prior sexual experience. Only 1 of these dogs showed sexual behaviour before chemical castration, this behaviour disappeared completely after the treatment with deslorelin. The other dogs of the pilot study which showed sexual behaviour before chemical castration without prior sexual experience also showed a major decrease or a complete reduction of this behaviour after treatment. Therefore, sexual experience also does not seem to play a role in the behavioural effect of chemical castration. None of the dogs of the telephonic follow-up study had sexual experience before chemical castration. Nothing is known about the duration of the problem behaviours in the pilot study and in the telephonic follow-up study. So nothing can be said about the role of experience regarding other behaviours in the case of chemical castration.     


4.3. Influence of age at castration

The testicles start secreting androgens that act upon the neural structures responsible for initiating reproductive behaviour at puberty (Resko, 1970). At this time an increase in testosterone production is seen in male dogs. This coincides with testicular growth and the induction of spermatogenesis. Pre-pubertal dogs have high concentrations of LH and low values of testosterone. This is indicative for an immature pituitary-gonadal axis (Günzel-Apel et al., 1994). 
The social behaviour of the pre-pubertal male dog can involve a number of sexual responses like mounting, thrusting and exploration of the genitalia of other dogs (Hart, 1968). 

Pre-pubertal surgical castration usually prevents the occurrence of the normal mating pattern in adult animals. In a study by Boeuf (1970) the effect of pre-pubertal surgical castration on copulatory behaviour was investigated. The dogs used in this experiment were castrated at 40 days of age. On sexual responsiveness, sexual attractiveness and aggressiveness there was only a little difference when early surgical castration was compared to  surgical castration at a mature age. Mounting behaviour was unchanged after early castration. Nevertheless, the pre-pubertal castrated dogs lost the ability to lock with the bitch, probably because of the smallness of the penis which fails to develop in the absence of androgenic secretions from the testicles. They also lost the ejaculatory reflex in most cases. This was expected, since this is the first component of copulation that declines following surgical castration (Boeuf, 1970). 
Comparable results were mentioned in a study by Beach (1970): pre-pubertal castrated males and intact males showed similar behaviour as it comes to the mounting and thrusting elements of the mating pattern. Intromission and ejaculation behaviour was clearly affected by pre-pubertal surgical castration. Early surgical castration also caused a failure to lock after intromission had been accomplished (Beach, 1970). 
It can be concluded from these studies that pre-pubertal surgical castration does not cause a decline in sexual libido when compared to mature surgical castration (Boeuf, 1970, Beach, 1970). There was also no difference found in sexual libido between pre-pubertal surgically castrated dogs and intact mature dogs in the study by Beach (1970). The interval between castration and behavioural tests was 18 months in this study. However, complete copulations were prevented by early surgical castration (Boeuf, 1970; Beach, 1970). According to other studies sexual behaviour will disappear after surgical castration, but can be retained for months or years after castration before this reduction is seen (Hart, 1968, Hart, 1974). Therefore, the interval of 18 months in the study by Beach (1970) could be to short to notice a decline in sexual behaviour in the early castrated dogs. 
In another study there was also no correlation found between the age of the dog at the time of surgical castration and the decline in the objectionable male dog behaviour (Hopkins et al., 1976).  Neilson et al. (1997) also found no relationship between effects of surgical castration and age at the time of castration (Neilson, 1997).  

In a retrospective cohort study by Spain et al. (2004) a comparison was made between early-age gonadectomy (< 5,5 months) and gonadectomy at normal age (> 5,5 months). There were 1,842 dogs included in this study, all of which were castrated and adopted from an animal shelter before the age of 1 year. Follow-up was available during 11 years after surgery. The owners completed a questionnaire about their dog. A decreasing age at surgical castration was associated with an increase in sexual behaviour. This was a surprising outcome and no biological mechanism could be found to explain this association. However, according to Hart (1976) puppies can go through a period of mounting people, dogs or objects. This behaviour often ceases when they mature (Hart, 1976). This phenomenon could be an explanation for the sexual behaviour of the early-age castrated males. Furthermore: a significant interaction was found between age at surgical castration and sex for 3 behaviours: aggression toward family members, barking at visitors and excessive barking that bothered a household member. These 3 behaviours were more frequent among male dogs that were castrated before the age of 5,5 months. This association was probably an artefact of the shelter’s screening procedure. Dogs that showed aggression when they were administered to the shelter were euthanatized, especially when they were older than 6 months of age. For this reason, many of the late-age castrated dogs were removed from the study. There was also a significant association between the 3 behaviours: for dogs without aggression, there was no association between barking and age at surgical castration. Because of this association, the removal of the late-age castrated aggressive dogs caused a removal of the late-age castrated dogs prone to excessive barking (Spain et al., 2004). 

There does not seem to be a relationship between age at surgical castration and effect of castration on the behaviour of the male dog. The only study which showed different results is the study by Spain et al. (2004). There seems to be a difference between species when it comes to the influence of age at surgical castration: for example, pre-pubertal castrated male cats are sexually inactive (Rosenblatt, 1958). 
The dogs of the pilot study were between 8 months and 5 years of age. So none of these dogs were chemically castrated at an pre-pubertal age. The minimum age of the dogs of the prospective study (and the telephonic follow-up study) is 1,5 years. Therefore, all of the chemically castrated dogs will be adult males. Pubertal dogs go through a period of behavioural changes and will therefore not form a very homogeneous output group. 


4.4. Influence of the adrenals 

The zona fasciculata of the adrenals produce and release a small amount of androgens under the influence of ACTH which is released by the anterior pituitary (Rijnberk, 1996). Compared to the amount of androgens produced by the testis this production is minimal (Knol et al., 1989). 
Some male dogs show persistent sexual behaviour after surgical castration. Surgical castration can result in an increase in the size of the adrenal cortex in male vertebrates (Warren et al., 1956). Sometimes it is argued that the persistence of sexual behaviour is due to compensatory increases in output of adrenal androgen (Hart, 1968).  

A lot of studies have been conducted involving adrenalectomy (Hart, 1968). The role of the adrenals in maintaining sexual behaviour has been studied in male hamsters, cats, guinea pigs, rats and dogs. The animals used in these studies were kept healthy with desoxycorticosterone acetate (DCA) after adrenalectomy (Warren et al., 1956). 
Bloch (1968) cited that adrenalectomy was not found to influence the sexual behaviour of male rats following surgical castration. The adrenal glands did not appear to have any influence in the mediation of sexual behaviour in rats (Bloch, 1968). 
In a study by Schwartz et al. (1954) the effect of adrenalectomy upon mating behaviour in castrated dogs was studied. The hypothesis that survival of sexual behaviour in castrated males depends upon hormones secreted by the adrenal cortex was tested. After adrenalectomy there was no significant difference found in mating behaviour compared to the situation after surgical castration but before adrenalectomy. Therefore, the persistence of mating behaviour after surgical castration did not depend upon hormones of the adrenal gland in the male dog (Schwartz et al., 1954). 
The effect of adrenalectomy upon mating behaviour in the golden hamster was examined in a study by Warren et al. (1956). Removal of the adrenals of adult intact male hamsters had no effect on the sexual behaviour. Removal of the adrenals of castrated adult male hamsters also had no effect on the reproductive behaviour of these animals (Warren et al., 1956). 
After adrenalectomy in addition to surgical castration the sexual behaviour also persisted for the same period of time in guinea pigs (Resko, 1970).   

It can be concluded that the adrenals do not seem to have an influence on the maintenance of sexual behaviour after surgical castration in males in different animal species. There are no studies available concerning the role of the adrenals in the maintenance of other problem behaviours after surgical castration. There are also no studies available concerning the role of the adrenals in the possible maintenance of problem behaviours after chemical castration.  


4.5. Influence of testosterone 

During a critical developmental period the brain has to be exposed to testosterone for the brain tissue to be able to mediate male behaviour later in life. If the brain is not exposed to testosterone during this period the central nervous system will only mediate female behaviour (Knol et al., 1989). For male dogs the overall testosterone level is 0,15 ng/ml for the first 20 days of life. This is 0,10 ng/ml for female dogs. According to this low level of testosterone for neonatal males a possible surge in secretion will occur during the prenatal period (Hart et al., 1979).

All steroid hormones, including testosterone are derived from cholesterol. Testosterone can have a direct interaction with the androgen receptor or an indirect interaction. The indirect interaction is caused by the active metabolite dihydrotestosterone, which has a higher affinity for the androgen receptors (Rijnberk et al., 1996). Testosterone is metabolized by an enzyme complex including 5α-reductase and aromatase in many target sites. The produced metabolites can act as mediators for a lot of actions which testosterone exerts on its target sites. Dihydrotestosterone, which is synthesized from testosterone by the action of the enzyme 5α-reductase, can exert the same influence on brain as testosterone itself in mice but not in hamsters (Knol et al., 1989). Testosterone can also be metabolized in estradiol by the aromatase enzyme. This enzyme is distributed only in hypothalamic and limbic brain areas in mammals. These areas are involved in the regulation of sexual and aggressive behaviour (Trainor et al., 2006). Leydig cells as well as Sertoli cells can also produce estrogens. The peripheral conversion of testosterone to estradiol is however most important (Rijnberk, 1996). Therefore, the behavioural effects of testosterone in the brain can be achieved by its metabolites (Knol et al., 1989). 
Oestrogen can modulate aggression. It can increase the probability and intensity of aggressive behaviour exhibited by male animals (domestic mice). But it can also decrease the probability and intensity of this behaviour (California mice). It is not yet clear how this is possible. The expression of estrogen receptor subtypes can be an important factor. It is however still unclear how these receptors modulate aggressive behaviour. There is some evidence that these receptors affect different motivational systems. A reduction of male sexual motivation is seen after selective deletion of the α estrogen receptor, whereas the β estrogen receptor is related to anxiety-like behaviour. Both behaviours are known to influence aggressive behaviour. There are multiple other pathways that could influence the effect of estrogen. Aromatase activity and distribution of receptor subtypes could be different between animals. Still, a lot of research has to be conducted (Trainor et al., 2006).
Testosterone itself is also known to effect aggression. It can promote aggression in a wide variety of animals. Although, there is no simple relationship between aggression and testosterone. A high level of testosterone does not always result in elevated aggression, since aggressive behaviour can also be expressed coinciding with low levels of testosterone (Trainor et al., 2006). However, dominant and aggressive male dogs often have a higher plasma testosterone concentration than submissive and less aggressive dogs (Knol et al., 1989).

The individual differences between dogs in response to surgical castration can not be due to differences in retention of testosterone in the blood since it is metabolized completely in a few hours after surgical castration (Hart, 1976). If the metabolites have an important influence on behaviour, then individuals with different central aromatase activity or oestrogen sensitivity (receptors) can behave very differently after surgical castration (Trainor et al., 2006).  
There is, however, a relationship between effects of surgical castration and androgen deficiency. This relationship is most obvious when it comes to sexual behaviour. There will be a restoration of mating behaviour after androgen replacement therapy. So the loss of mating behaviour after surgical castration must be due to an androgen deficiency (Dunbar, 1975). Similar results are mentioned in a study by Beach (1970): injections of testosterone propionate caused a general reversal of behavioural changes which had occurred following surgical castration of male dogs. The average lock duration increased, the percentage of tests with locking increased and there was a prolongation of rapid thrusting. Injection of pre-pubertal castrated dogs with testosterone propionate had effects upon the intromission and ejaculation elements of the copulatory behaviour. Some dogs which had never accomplished intromission of the penis before treatment did so under the influence of testosterone replacement. Other dogs showed some prolongation of the period of rapid thrusting (Beach, 1970). Daily injections of testosterone propionate also restored copulatory behaviour in castrated male rats. This copulatory behaviour disappeared after cessation of treatment (Beach, 1970). After the loss of sexual behaviour following surgical castration it could also be restored again by testosterone replacement in guinea pigs (Resko, 1970).

In early experiments there was the assumption that gonadal androgen is less important in maintaining sexual dimorphic behaviour in animals with a more highly evolved brain, like dogs and cats (Beach et al., 1955). Other factors than androgen influence could be responsible for the maintenance of some behaviours after surgical castration. A few studies were conducted to investigate the influence of different brain regions on sexual behaviour.  
Copulatory behaviour was not eliminated in male cats after the unilateral removal of the neocortex. However, this behaviour was abolished by complete removal of the neocortex. Prolonged treatment with testosterone propionate could not restore sexual activity in these cats (Beach et al., 1955). Cortical lesions in male rats caused a lowering of sexual responsiveness. No interference with the organisation of the mating pattern was seen. This effect was in contrast with the effect of cortical lesions in male cats. These cats gave evidence of intense sexual excitement after cortical lesions. They were however unable to complete the coital pattern. This different effect of cortical lesions could be explained by the way and the degree in which the cortex contributes to behaviour in carnivores and rodents. The rather simple cortex of rodents is primarily responsible for the responsiveness of the animal. The cortex of carnivores is more differentiated and is responsible for the coordination and execution of animal responses (Beach et al., 1955).  

There must be an association between testosterone and behavioural changes after surgical castration since androgen replacement therapy restores sexual behaviour in all examined species. It is not yet clear how this is possible. Testosterone is metabolized within a few hours after gonadectomy, but it can take months to years for the sexual behaviour to decrease after surgical castration. Perhaps the metabolites are responsible for the delayed effect of surgical castration on behaviour. Another possibility could be that a very low plasma concentration of testosterone remains present for longer periods of time than is expected. These concentrations could be below the level of detection of most assays but enough to cause an effect. There could be an individual difference in the level of this remaining testosterone concentration resulting in different results after surgical castration. More research has to be done involving this subject, for example titration studies in which increasing amounts of androgens are administered to castrated male animals. Unfortunately, these studies are not available. 
There was no endocrinological data of the dogs of the pilot study. This data will be available for the dogs of the prospective study. A relationship between testosterone concentration and behavioural changes after chemical castration might be found.    


4.6. Using questionnaires 

For the retrieval of information regarding a dogs behaviour in it’s normal environment the use of questionnaires is the best known option. In practice, it is not possible for a researcher to study the behaviour of every dog in it’s natural environment for an extended period of time. However, the use of questionnaires can have some disadvantages. 





After the use of the GnRH agonist deslorelin (4,7 mg) a major behavioural change can be seen in male dogs. This change can be seen after a few weeks following implantation. The treatment seems to be reversible; the pre-treatment behaviour returned in the dogs of which the owners received the questionnaires after the activity of the implant has ceased. However, a distinct difference between the duration of activity of the S6 and the S12 implant is not seen. 
The effect of chemical and surgical castration on a few behaviours of male dogs mentioned in this paper are comparable. Roaming behaviour, inter-male aggression, sexual behaviour and urine marking are affected comparably by chemical and surgical castration. Although a decline in sexual behaviour after chemical castration appears to occur sooner than a decline in sexual behaviour after surgical castration. Sexual behaviour can be retained for up to several years but will vanish eventually after surgical castration. After chemical castration the dogs will also decrease or completely lose their sexual behaviour, however, this change can already be seen after 3 weeks. The effects of chemical and surgical castration on the activity of the dog are also comparable.
A reduction of testis circumference can be seen after treatment when the testosterone concentration reduces which will be evidence of the activity of the implant. In this way the owner can see if the implant is active. The testis circumference will increase again when the activity of the implant ceases.   
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Attachment 1: Overview of studies involving the GnRH agonist deslorelin 

Reference	Route of administration	Animals used	No. of animals	Dosage used	Hormone assays 	Method	Testes circumference	Abstract 
Aspden et al.(exp. 1) 	Slow-release bioimplants 	Bulls  	14	25 ųg/24h	LH, T2 	LH (LH challenge, mean)T2 (mean)	No difference after 10 days 	LH: small increase (6h p.i.), normal (3-10d), no increase after challenge. T2: increased (3-10d).  
Aspden et al.(exp. 2) 	Slow-release bioimplants	Bulls	18	50 ųg/24h	T2	Mean 	Increase in diameter on day 120 	T2: increased 
Junaidi et al.(2007) 	Implant (Peptech)	Dogs 	20	6 mg	LH, T2 	Mean, GnRH-challenge, LH-challenge 	N/A	LH: initial rise followed by undetectable values until 101 days p.i. (<0.06 ng/ml)T2: initial rise followed by undetectable values until 101 days p.i.After GnRH-challenge: LH and T2 reduced response (day 15), no response (day 100) After LH-challenge: T2 reduced response, by day 26 no response 
Trigg et al. (2001) 	Implant (Peptech)	Dogs 	30	3, 6, 12 mg 	T2 	Mean 	N/A 	T2: within 6-25 days < 1 ng/ml in al groups; this level was maintained for 3 months to 2,7 years (dose dependent) 
Junaidi et al. (2003) 	Implant (Peptech) 	Dogs 	8	6 mg 	LH, T2 	Mean 	Below control values after 5 weeks, maintained for 40-45 weeks 	LH: initial rise, at 5h normal values; undetectable from 20 days until week 49; week 50 normal values  T2: initial rise, at 5h normal values; within 3 weeks undetectable values; week 52 normal values 
D’occhio et al. 	Slow-release bioimplants 	Bulls	24	0.15, 0.6, 1.2  ug/kg/d	LH, T2	Mean 	Increased 	LH: rise within 8h, day 7-102 higher values than controlsT2: rise within 8h, day 7-102 higher values than controls
Schoemaker et al. 	Implant (Peptech)	Ferrets 	21	9,4 mg	T2, FSH 	Mean 	Decreased 	T2: decreased FSH: decreased 
Herbert et al. 	Implant (Peptech)	Marsupial(Wallabies)	24	5, 10, 20 mg(1 implant = 5 mg) 	LH, T2 	Mean 	Increased 	LH: rise after 2h, peak between 4 and 6h, after 7d pre-treatment levels, remained like this for the rest of the study  T2: increase after 2h, reach plateau for 24h p.i., remained higher than control values   

Table 1: The effect of the GnRH agonist deslorelin in different species. 


Attachment 2: Overview of studies involving different GnRH agonists. 

Reference	GnRH agonist 	Route of adminis-tration	Animals used	No. of animals	Dosage used	Hormone analysis	Method	Testes circum-ference	Abstract 
Ronayne et al. 	Leuprolide 	Mini-osmotic pumps for continuous delivery for 28 days (s.c.)	Bulls 	35 	3,3 ug/kg/d10 ug/kg/d	LH, T2	LH (basal, mean)T2 (mean)	No effect   	LH: decrease in pulse frequency, mean LH no differenceT2: elevated 
Knol et al.  	Gonadorelin 	i.v. administration at weekly intervals 	Dogs  	6	0,01 / 0,1 / 1 / 10 / 100 ug/kg 	LH, T2	Mean 	N/A 	At each dose: increase in LH and T2 (increase is dose-dependent) followed by a decrease 
Inaba et al. 	Leuprolide 	Single subcutaneous injection 	Dogs 	15	0,1 mg/kg1,0 mg/kg 	LH, T2 	Mean 	N/A	LH and T2: initial rise, followed by a decline to below normal values (during 5 wk at 1,0 mg/kg, less at 0,1 mg/kg)
Xue et al. 	Leuprolide 	Single injection i.m. 	Pigs 	30	50 ug/kg 200 ug/kg 	LH, T2	Mean 	Decreased ( 200 ug > 50 ug) 	LH: after 5h 320% increase (200 ug) and 560% (50 ug); 29h after injection normal values T2: 275% increase at 5h (200 ug), followed by a decrease (80% below control) remain low; after 29h 180% increase (50 ug), followed by a decrease (day 8 77% less), after 25d increase to normal values. 
Vickery et al. (1985) 	Nafarelin 	Daily s.c. injections for 44 days 	Dogs 	 9	0.5 ug/kg2.0 ug/kg	LH, FSH, T2	Basal 	Decreased (more rapidly at higher dosage) 	LH: rise after 2-4h after 1st injection, by 21 days a decline to 0.2 ng/ml or less (this response is faster > concentration)FSH: rise after 2-4h after 1st injection (not to the same degree as LH), followed by a marginal declineT2: initial rise followed by a decrease (levels reach castrate levels after 4d with 2.0 ug, after 21d with 0.5 ug) 
Kher et al. 	Buserelin	Daily s.c. injections for 30 and 60 days 	Mice 	44	100 ug/kg/day (60 days)1000 ug/kg/day (30 days) 	T2	Mean 	Decrease of 10% (30 days group)Decrease of 13% (60 days group)	T2: decreased in both groups 
Schneider et al. 	Triptorelin 	Single i.m. injection; release for 4 weeks 	Pigs 	38	7.5 mg 	LH, T2, Estradiol	Mean 	Continuous decrease in length and width 	Initial short-time rise, after 7d followed by a decrease to below control values (for the entire study, 28 days) 
Lincoln et al. 	Buserelin 	Osmotic mini-pumps implanted s.c.; release for 21 days  	Sheep 	8	50 ug/day 	LH, FSH, T2	Mean 	Small decrease in diameter 	LH: Initial rapid increase in plasma concentration, peak at day 1, above pre-treatment values until day 7, no pulses, normal values  T2: rapid increase, peak at day 7, above pre-treatment values until day 10, normal valuesFSH: transient change (increase in 2 rams, even in other 2) 
Boyle et al. 	Buserelin	Mini-osmotic pumps for continuous delivery for 28 days (s.c.); slow release implant for continuous delivery for 28 days 	Horses 	9	60ug/day (1 pump); 240ug/day (2 pumps); 30-50ug/d (implant) 	LH, FSH, T2	Mean 	N/A 	General response to all doses: increase in LH, FSH, T2 after 15 minutes, peak at 7h, followed by a rapid decline to basal or lower values within 2-5 days  
Lincoln 	Buserelin 	Mini-osmotic pumps for continuous delivery for 4 weeks; new implants at 3-4 weeks intervals (total 72 days)	Red Deer 	8	180ug/day 	LH, T2 	Mean 	Increase 	Increase in LH and T2, decline after 10 weeks; increase in aggressive behaviour 










Een tijd geleden heeft u meegedaan aan een pilot studie voor het onderzoek; chirurgische en chemische castratie: gevolgen voor het gedrag. Er is toen bij uw hond een implantaat ingebracht en er is aan u gevraagd een vragenlijst in te vullen en terugkoppelingen via e-mail te sturen. We zijn ondertussen begonnen aan het eigenlijke onderzoek. Ik ben nu bezig met het verwerken van de informatie die we verkregen hebben via de pilot studie. De pilot was geen volledig onderzoek waardoor er nog veel nuttige informatie ontbreekt. Ik zou dan ook aan u willen vragen om een aantal vragen te beantwoorden zodat er een beter overzicht verkregen kan worden. 

1.	Wat is de reden voor chemische castratie?
2.	Heeft uw hond wel eens gedekt vóór de implantatie?
3.	Heeft uw hond deelgenomen aan gedragstraining (cursus) na de implantatie? Zo ja; welke cursus, wanneer begonnen en duur?
4.	Was er sprake van een duidelijke gedragsverandering na de implantatie?
5.	Kunt u aangeven in hoeverre onderstaande gedragingen veranderd zijn na castratie (indien van toepassing op uw hond)?
a.	Wegloop gedrag
b.	Agressie naar mensen (bekend en onbekend)
c.	Agressie naar honden (bekend en onbekend, reu en teef)
d.	Urine markeren
e.	Rijgedrag 
f.	Overig (ander gedrag dat duidelijk veranderd is)
6.	Hoe lang duurde het voordat er sprake was van een gedragsverandering?
7.	Hoe lang na de implantatie merkte u dat de veranderingen weer stopte?
8.	Zijn de testes van uw hond kleiner geworden tijdens implantatie? Zo ja; hoe lang duurde het voordat ze kleiner werden, hoeveel kleiner werden ze, hoe lang duurde het voordat ze weer van normale grote waren?
9.	Is uw hond na de chemische castratie chirurgisch gecastreerd? 
10.	Wat is het effect van de chirurgische castratie op het gedrag van uw reu? 








Attachment 4: Telephonic follow-up questionnaire 


Hieronder volgen 18 follow-up vragen aan de eigenaren die met hun reu aan het onderzoek meedoen. Er wordt telefonisch contact opgenomen op 1, 3 en 5 weken na de behandeling.

Gedragsobservaties door eigenaar, steeds wordt gevraagd naar verandering t.o.v. de situatie vóór behandeling.

1. Is uw hond angstiger geworden?
	0  Ja, duidelijk angstiger
	0  Ja, enigszins angstiger
	0  Niet angstiger, niet minder angstig
	0  Nee, enigszins minder angstig
	0  Nee, duidelijk minder angstig
	0  Nee, niet meer angstig gezien
	0  NVT, mijn hond was en is nooit angstig

2. Is uw hond beweeglijker geworden?
0  Ja, duidelijk beweeglijker
	0  Ja, enigszins beweeglijker
	0  Niet beweeglijker, niet minder beweeglijk
	0  Nee, enigszins minder beweeglijk
	0  Nee, duidelijk minder beweeglijk

3. Is uw hond speelser geworden?
0  Ja, duidelijk speelser
	0  Ja, enigszins speelser
	0  Niet speelser, niet minder speels
	0  Nee, enigszins minder speels
	0  Nee, duidelijk minder speels
	0  Nee, niet meer speels gezien
	0  Nvt, mijn hond was en is nooit speels 

4. Slaapt uw hond meer?
0  Ja, slaapt duidelijk meer
	0  Ja, slaapt enigszins meer
	0  Slaapt niet meer en niet minder
	0  Nee, slaapt enigszins minder 
	0  Nee, slaapt duidelijk minder

5. Luistert uw hond beter? (bijv. naar commando’s af, lig en blijf)?
0  Ja, luistert duidelijk beter
	0  Ja, luistert enigszins beter
	0  Luistert niet beter en niet minder goed
	0  Nee, luistert enigszins slechter 
	0  Nee, luistert duidelijk slechter

6. Is uw hond agressiever geworden? Alle categorieën aangeven in tabel (vraag 9) scoren
	A. Naar mensen?
0  Ja, hij is duidelijk agressiever
	0  Ja, hij is enigszins agressiever
	0  Hij is niet meer of minder agressief dan voorheen.
	0  Nee, hij is enigszins minder agressief 
	0  Nee, hij is duidelijk minder agressief
	0  Nee, niet meer agressief gezien
	0  Nvt, mijn hond was en is nooit agressief

	B. Naar andere reuen?	
0  Ja, hij is duidelijk agressiever
	0  Ja, hij is enigszins agressiever
	0  Hij is niet meer of minder agressief dan voorheen.
	0  Nee, hij is enigszins minder agressief 
	0  Nee, hij is duidelijk minder agressief
0  Nee, niet meer agressief gezien
	0  Nvt, mijn hond was en is nooit agressief

C. Naar andere teven?	
0  Ja, hij is duidelijk agressiever
	0  Ja, hij is enigszins agressiever
	0  Hij is niet meer of minder agressief dan voorheen.
	0  Nee, hij is enigszins minder agressief 
	0  Nee, hij is duidelijk minder agressief
0  Nee, niet meer agressief gezien




7. Vertoont uw hond meer seksueel gedrag dan voorheen?
Onder seksueel gedrag verstaan we: bestijgen van en/of rijden op mensen, dieren of voorwerpen, waarbij ook de penis uitgeschacht kan worden en waarbij eventueel sprake kan zijn van ejaculeren.
0  Ja, hij vertoont duidelijk meer seksueel gedrag
	0  Ja, hij vertoont enigszins meer seksueel gedrag
	0  Hij vertoont niet meer en niet minder seksueel gedrag dan voor de 	behandeling
	0  Nee, hij vertoont enigszins minder seksueel gedrag
	0  Nee, hij vertoont duidelijk minder seksueel gedrag
	0  Nee, hij vertoont geen seksueel gedrag meer
	0 Nvt, mijn hond toonde en toont nooit seksueel gedrag 

8. Tilt uw hond minder vaak zijn poot op tijdens het uitlaten?
0  Ja, hij tilt zijn poot niet meer op
0  Ja, hij tilt duidelijk minder vaak zijn poot op
	0  Ja, hij tilt enigszins minder vaak zijn poot op
	0  Hij tilt niet vaker en niet minder vaak zijn poot op
	0  Nee, hij tilt wat vaker zijn poot op
	0  Nee, hij tilt duidelijk vaker zijn poot op
	0  Nvt, mijn hond tilde en tilt nooit zijn poot op 

9. Loopt uw hond vaker weg tijdens het uitlaten als hij los loopt?
0  Ja, hij loopt duidelijk vaker weg
	0  Ja, hij loopt enigszins vaker weg
	0  Hij loopt niet vaker en niet minder vaak weg
	0  Nee, hij loopt enigszins minder vaak weg
	0  Nee, hij loopt duidelijk minder vaak weg
	0  Nee, hij loopt niet meer weg 
	0  Nvt, mijn hond liep en loopt nooit weg (bijv. altijd aan de lijn)


10. Trekt uw hond meer aan de lijn dan voorheen?
0  Ja, hij trekt duidelijk meer
	0  Ja, hij trekt enigszins meer
	0  Hij trekt niet meer en niet minder 
	0  Nee, hij trekt enigszins minder 
	0  Nee, hij trekt duidelijk minder 
	0  Nee, hij trekt niet meer 
	0  Nvt, mijn hond trok en trekt nooit

11. Zijn er sinds de ingreep veranderingen in de leefomgeving van de hond geweest? 









Vragen met betrekking tot de fysieke kenmerken van de hond, steeds wordt gevraagd naar verandering t.o.v. de situatie vóór behandeling:

13.  Heeft uw reu meer last van voorhuidontsteking gekregen?
 (pussige, geelgroene uitvloeiing uit de voorhuid)? **
0  Ja, duidelijk meer last
	0  Ja, enigszins meer last
	0  Niet meer en niet minder last
	0  Nee, enigszins minder last
	0  Nee, duidelijk minder last
	0  Nee, geen voorhuidontsteking meer gezien
	0  Nvt, mijn hond heeft er nooit last van gehad 





15.  Is de eetlust van uw reu toegenomen? **
0  Ja, duidelijk toegenomen
	0  Ja, enigszins toegenomen
	0  Niet toe- en niet afgenomen
	0  Nee, enigszins afgenomen
	0  Nee, duidelijk afgenomen
	0  Nee, geen eetlust meer 

16.  Is de vachtconditie van uw reu slechter geworden? **
0  Ja, duidelijk slechter geworden
	0  Ja, enigszins slechter geworden
	0  Niet beter en niet slechter geworden
	0  Nee, enigszins beter geworden




17. Zijn er medische complicaties opgetreden na de behandeling? 
										Nee / Ja
nl.: (castratie / implantatie):…………………………………………………………….….
……………………………………………………………………………………….………….

Alleen in geval van implantatie:

18.  Zijn de testes van uw reu kleiner geworden?
0  Ja, duidelijk kleiner geworden
	0  Ja, enigszins kleiner geworden
	0  Niet groter en niet kleiner geworden
	0  Nee, enigszins groter geworden






Bijzonderheden / opmerkingen ten aanzien van het gedrag van mijn hond:
……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………








Attachment 5: Results of pilot study (1/3) 


VETWARE NUMMER	Naam eigenaar	Naam hond	Ras en gewicht	Geboortedatum	Datum implantatie	Implantaat	Reden castratie	Gedekt voor implantatie	Cursus gevolgd na implantatie
0606448	H.G.S. van Dodeweerd	Foster	Kooiker-hondje,11,7 kg	08-04-05	11-08-2006	6 maanden,Batch no: SBL036A	Overmatig opdringerig t.o.v. teven; agressie t.o.v. (intacte) reuen	Ja	Ja 
0802280	Reina Stoker	Frodo	Labrador Retriever	16-05-06	02-04-2008	6 maanden,Batch no: SCN058A	Agressie naar andere honden (vooral reuen); sterk gericht op teefjes; vreselijk trekken aan de riem; wegloop gedrag; slecht reageren op commando’s; markeren bij anderen in huis; onrust bij training 	Nee	Ja; gehoorzaamheid en gedrag training (al vanaf pup)
0801131	Suzan Nooijen	Max	Labrador Retriever	24-05-07	20-02-2008	12 maanden,Batch no: SEN059A11	Rijgedrag op andere honden zowel reuen als teefjes (niet op mensen), sloopgedrag  	Nee 	Nee 
0709405	Stanny Meijer	Balou	Engelse Springer Spaniel,27,7 kg	30-07-05	19-12-2007	12 maanden,Batch no: SBN057A	Heftig reageren op loopse teven (incl. rijgedrag); tegen eigenaar van teef plassen; geen rust kunnen vinden	Nee	Ja; gehoorzaamheids cursus training A en B 
0800875	Raymond Plusjé 	Joey	Middenslag Schnauzer,17,0 kg	19-06-06	04-02-2008	6 maanden, Batch no: SCN058A	Veel interesse in teven; (meestal geen problemen met reuen); rijden op reuen en teven; veel markeren; moeilijk trainbaar (alleen maar oog voor de teefjes)	Nee 	Nee; wel behendigheid (al vanaf 10 maanden leeftijd)
0707624	Ineke Smith	Luuk	Labrador Retriever,34,0 kg 	12-01-02	24-10-2007	12 maanden,Batch no: SBN057A11	Agressie naar andere reuen (lijkt op angst agressie  hond onzeker  aanval is beste verdediging)  (liever geen castratie i.v.m. shows/wedstrijden) 	Nee 	Nee; wel jachttraining in Duitsland 
0707977	E. Garritsen  J. War-merdam	Moos	Weimarse Staande	29-07-02	24-10-2007	12 maanden,Batch no: SBN057A11 	Vanwege thuis situatie (loopse teef in huis), ze willen nog niet definitief castreren 	Nee 	Onbekend
0704608	Dorothea Pronk	Indy	Dalmatiër,31,8 kg 	13-08-03	13-06-2007	12 maanden, Batch no: SGM046A11	Agressie t.o.v. andere reuen 	Nee 	Nee 
0800188	Margriet Blokland	Migo	Heide-wachtel,21,5 kg	26-01-07	30-01-2008	12 maanden,Batch no: SBN057A11	Rijgedrag; soms onbereikbaar voor commando’s; soms agressief; snuffelt veel in kruis van mensen 	Nee 	Ja; divers 
0800439	Monique Markus	Rens	Labrador Retriever,31,0 kg	02-09-04	06-02-2008	6 maanden,Batch no: SCN058A	Gefixeerd op teefjes (loopt weg van huis, thuis janken); agressie t.o.v. andere reuen (met bijten); rijden op reuen en teven  	Nee 	Nee 
0800944	T. Maters 	Lino	Kruising,9,2 kg	01-11-06	30-07-2008	12 maanden,Batch no: SLN067A	Voorhuidontsteking; kijken wat voor een effect castratie op de hond zal hebben	Onbekend 	Nee 
0707623	M. Visser	Bram	Labrador Retriever,34,0 kg 	04-03-05	24-10-2007	12 maanden,Batch no: SBN057A11	Agressie t.o.v. reuen; veel interesse in loopse teefjes(liever geen castratie, moet ooit misschien nog dekken) 	Nee 	Nee (eigenaren zijn wel al lang bezig met jachttraining) 
0708533	Esther Quatfass	Boef	Heide-wachtel,21,6 kg 	21-04-04	16-11-2007	12 maanden, Batch no: SBN057A11	Rijgedrag op gecastreerde reuen en teven (niet bij mensen); soms weglopen 	Nee	Onbekend
0708954	Mariska Ursinus	Boris 	Labrador Retriever,32,4 kg 	26-03-05	12-12-2007	12 maanden, Batch no: SBN057A11	Extreme fixatie en rijgedrag op teefjes (hond wordt dan onbereikbaar, reageert niet op correcties)	Nee 	Nee
0802804	Debby van de Weerd	Snow	Siberische Husky,21,6 kg 	23-09-07	07-05-2008	6 maanden, Batch no: SCN058A	Extreme interesse in teefjes; dominantie t.o.v. reuen (conflict met andere honden in huis) 	Nee 	Ja; gedrag en gehoorzaamheid 
0706080	M. Jansen	Atlas	Golden Retriever,38,5 kg 	15-12-05	08-08-2007	12 maanden, Batch no: SGM046A11 	Macho gedrag; rijgedrag; onbereikbaar zijn; extreem reageren als op plek loops teefje is geweest 	Nee 	Nee
0800138*	H. ten Have	Nica	Tervueren-se Herder,27,0 kg 	02-12-05	07-01-2008	6 maanden, Batch no: SCN058A21	Rangorde conflict tussen honden; agressie naar mensen (ook eigenaar); uitvallen zonder aangeven 	Nee 	Nee 
Onbekend*	H. ten Have	Frodo 	Tervueren-se herder, 27,0 kg  	26-07-04	07-01-2008	6 maanden, Batch no: SCN058A21	Rangorde conflict tussen honden 	Nee 	Nee 
0707066	Ineke Custers	Mazzel	Golden Retriever,32,5 kg  	05-06-06	12-09-2007	12 maanden, Batch no: SBN057A11	Ongedurig; binnen urineren bij mensen die reuen in huis hebben; interesse voor loopse teefjes; honden bespringen  	Onbekend	Onbekend
0602559	Martin Zuidam	Buddy	Labrador Retriever,37,0 kg 	27-01-05	29-03-2006	6 maanden, Batch no: SBL036A	Dominant gedrag 	Onbekend	Onbekend
0215765	Laura Lancee	Daigo	Parson Russel Terrier	05-08-01	25-04-2007	12 maanden,Batch no:SGM045A11	Hond onbereikbaar tijdens hondensport; agressie t.o.v. intacte reuen	Ja (2 maal)	Nee (wel agility, racing en werkhonden sport) 





VETWARE NUMMER	Gedragsverandering na implantatie(ja/nee)	Start gedragsverandering	Overzicht gedragsveranderingen
			Wegloop gedrag	Agressie naar mensen (bekend/onbekend)	Agressie naar honden (bekend/onbekend/reu/teef)	Urine markeren	Rij-gedrag	overig
0606448	Ja 	Na 2 maanden 	Nvt 	Nvt 	Agressie naar reuen is verminderd 	onveranderd	Helemaal verdwenen	Slomer; soms bang voor andere honden 
0802280	Ja 	Na 6 tot 8 weken   	Minder geworden (beter letten op de baas); loopt alleen weg als hij andere hond ziet 	Agressie t.o.v. kinderen van eigenaar (bij afpakken van iets lekkers en bij correctie), voorheen nooit agressie naar mensen  	Duidelijk verminderd  minder agressie naar andere honden (uitvallen is altijd aangelijnd); op bekende honden nauwelijks reageren  	Duidelijk verminderd 	Nvt 	Minder interesse in teefjes; meer puppy trekken terug gekomen (spelen met sloffen e.d.); beter luisteren; geduldiger tijdens training; minder trekken aan de riem; rustiger in huis bij bezoek; minder blaffen; niet meer op voeten liggen  
0801131	Ja, maar niet heel duidelijk 	Onbekend 	Nvt 	Nvt 	Nvt 	Gelijk gebleven	Klein beetje afgenomen 	Minder sloopgedrag 
0709405	Ja 	Na 10 dagen 	Nvt 	Nvt 	Nvt 	Gelijk gebleven 	Duidelijk verminderd	Nee 
0800875	Ja 	Na 1 maand  rijgedrag verdwenenNa 2 maanden  rest van de veranderingen 	Nvt 	Nvt 	t.o.v. reuen toegenomen  aangelijnd uitvallen (nooit voor implantaat)	Onveranderd (nog steeds heel veel) 	Helemaal verdwenen	Iets makkelijker weg te krijgen bij een teefje; meer aandacht voor de baas tijdens trainen 
0707624	Ja	Na ongeveer 3 weken	Nvt	Nvt	Naar teven nooit agressief geweest; naar reuen is agressie gelijk gebleven	Gelijk gebleven	Nvt	Speelser; minder onzeker
0707977	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend
0704608	Ja 	Alle veranderingen na ongeveer 1 week 	Nvt 	Veel meer blaffen naar onbekenden 	Naar reuen (bekend en onbekend) duidelijk afgenomen; naar teven toegenomen agressie (gevecht met teef gehad, voorheen nooit)	Afgenomen 	Afgenomen 	Veel onzekerder in bepaalde situaties (in stad/station  vluchtgedrag); toegenomen spelgedrag; meer jagen; beter luisteren; toegenomen aandacht voor de baas 
0800188	Ja 	Na 3 weken 	Gelijk gebleven	Nvt 	Nvt 	Toegenomen 	Helemaal verdwenen 	Lijkt onzekerder en angstiger
0800439	Ja 	Na 6 weken  	Helemaal verdwenen	Verminderd 	Helemaal verdwenen (t.o.v. reuen) 	Duidelijk verminderd 	Helemaal verdwenen 	Interesse in loopse teefjes verdwenen; beter luisteren; aanhankelijker; geen voorhuidontsteking meer   
0800944	Nee 	Hond was nog onder invloed van vorig implantaat (6 mnd) 	Nvt 	Nvt 	Nvt 	Gelijk gebleven	Nvt 	Angstiger 
0707623	Ja 	Na 5 tot 6 weken 	Nvt 	Nvt 	Hond iets makkelijker te hanteren; minder gegrom naar eigen reu in huis 	Nvt 	Nvt 	Nvt 
0708533	Ja 	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend
0708954	Ja 	Rijgedrag meteen verdwenen; hond werd na paar maanden aantrekkelijk voor reuen  start agressie mensen en honden 	Nvt 	Erger geworden, na implantatie blaft hij meer naar vreemde mensen 	Erger geworden, hond werd aantrekkelijk voor andere reuen (deze gingen op hem rijden)  hond reageert door uit te vallen 	Duidelijk minder geworden 	Rijgedrag op teven is gestopt 	Rustiger 
0802804	Ja 	Na 6 weken 	Nvt 	Nvt 	Nvt 	Duidelijk verminderd	Nvt 	Meer relaxed; makkelijker in gareel te roepen; niet meer heftig reageren op teefjes; geen conflicten meer met de andere huis honden 
0706080	Ja 	Na 4 weken	Nvt	Nvt	Nvt	Duidelijk verminderd 	Helemaal verdwenen 	Minder trekken aan de riem; minder dominant t.o.v. reuen; speelser; rustiger; beter luisteren; eten van de straat
0800138*	Ja 	Na 1,5 maand	Nvt 	Rustiger naar mensen	Iets rustiger naar andere honden	Duidelijk verminderd	Helemaal verdwenen	Beter luisteren 
Onbekend*	Ja 	Na 1,5 maand 	Nvt 	Rustiger naar mensen	Iets rustiger naar andere honden 	Duidelijk verminderd 	Helemaal verdwenen 	Beter luisteren; vaker en sneller moe (tijdens wandeling gaat hond vaak liggen)
0707066	Ja 	Na 1 maand 	Onbekend 	Nvt 	Nvt 	Onbekend 	Helemaal verdwenen	Rustiger naar teefjes; buiten speelser; minder snuffelen tijdens wandelen
0602559	Ja 	Na 3 weken 	Onbekend	Onbekend	Onbekend	Onbekend	Helemaal verdwenen 	Onbekend
0215765	Niet overduidelijk; slechts in kleine opzichten 	Na ongeveer 1,5 maand 	Nvt 	Nvt 	Geen verandering	Geen verandering 	Nvt 	Beter bereikbaar tijdens hondensport (agility) en beter te begeleiden (in kleine mate); meer spelen met eigen hond

Table 3: Changes after chemical castration (2/3) 

VETWARE NUMMER	Einde gedragsveranderingen	Testes verkleining na implantatie(ja/nee)	Start testes verkleining	Einde testes verkleining	Chirurgische castratie na implantatie	Effect chirurgische castratie	Bijzonderheden
0606448	Na 2 jaar 	Ja; afname van 75% 	Na aantal weken	Nog steeds niet helemaal oude grootte terug 	Ja 	Geen interesse meer in teven; dominant gedrag wisselend; soms bang voor honden	
0802280	Na 5,5 maanden 	Ja; meer dan de helft  	Na 2 weken 	Na 5 maanden werden ze weer groter (daarna niet meer van toepassing i.v.m. chirurgische castratie)	Ja; na 6 maanden 	Hetzelfde als na implantatie, alleen nog sterker 	Hond geen last meer van voorhuidontsteking na implantatie 
0801131	Na ongeveer 8 maanden 	Ja; klein beetje	Onbekend	Nog steeds klein (na 9 maanden) 	Ja (na 9 maanden)	Nog onbekend	Geen 
0709405	Nog steeds werkzaam (na 10 maanden)	Ja; minstens de helft kleiner geworden 	Binnen 20 dagen 	Nog steeds klein (na 10 maanden) 	Nee  	Nvt 	Al 2 keer eerder een chemische castratie gehad  had ongeveer 4 weken effect (hond was rustiger) Vacht is dof en onregelmatig geworden 
0800875	Na 6 maanden 	Ja; tot grootte van een walnoot 	Na 3 tot 4 weken 	Na 6 maanden nieuw implantaat, dus niet de kans gekregen om groter te worden 	Nee 	Nvt 	Schuurt vaak met perineum over de grond  scrotitis (duidelijke oude littekens en depigmentatie); ligt met achterhand op harde en koude ondergrond.Heeft Tardak gekregen  veel verbetering. PI geen voorhuidontsteking meer.  08-2008 nieuw 6 mnd implantaat.
0707624	Na 14 maanden nog steeds werkzaam 	Ja; duidelijke afname	Na ongeveer 1 maand	Na 13 maanden iets toe aan het nemen in grootte, nog steeds niet op normale grootte (nu 14 maanden later)	Nee	Nvt	Geen 
0707977	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend
0704608	Na 6 maanden (weer vechten met reuen; niet luisteren; minder onzeker)	Ja 	Na paar dagen al duidelijk kleiner, na 3 weken helemaal weg 	Na 6 maanden (weer 1/3 van de normale grootte, nu nog steeds het geval)	Nee 	Nvt 	Testosteronbepaling na 16 maanden  < 0,02 ug/ml 
0800188	Nog steeds werkzaam (na 10 maanden)  	Ja; tot ¼ van oorspronkelijke grootte  	3 weken 	Nog steeds klein (na 10 maanden)	Nee 	Nvt 	Hond heeft geen last meer van voorhuidontsteking na implantatie 
0800439	Na 7 maanden kwamen aantal gedragingen terug (direct nieuw implantaat laten zetten) 	Ja 	Na 3 weken (tot 1/5 van oorspronkelijke grootte) 	Nvt	Nee 	Nvt 	Hond heeft opnieuw een implantaat 
0800944	Nog steeds werkzaam (na 4 maanden) 	Ja; meer dan de helft 	Waren nog klein door vorig implantaat 	Nog steeds klein (na 4 maanden) 	Nee 	Nvt 	Hond heeft al eerder een implantaat gehad (6 maanden); na implantatie geen voorhuidontsteking meer  
0707623	Nog niet echt veranderd (nu ongeveer 1 jaar verder)	Ja; bijna helemaal verdwenen 	Na 2 weken 	Vanaf nu (1 jaar later) beginnen ze groter te worden	Nee 	Nvt 	Geen 
0708533	Onbekend	Onbekend	Onbekend	Onbekend	Ja 	Onbekend	Onbekend
0708954	Nog steeds werkzaam (nu 10 maanden later) 	Ja; van 4 cm naar 2 cm 	Na ongeveer 1 maand 	Nog steeds klein (10 maanden later)	Nee 	Nvt 	Geen 
0802804	Na 6 maanden	Ja; meer dan de helft 	Na 6 weken 	Na 6 maanden 	Ja 	Hetzelfde als bij implantaat 	Geen 
0706080	Na 12 maanden	Ja 	Na 6 weken 	Na 11 maanden	Ja	Hetzelfde als bij implantaat 	Geen 
0800138*	Nog steeds gedeeltelijk werkzaam (nu 10 maanden later) (alleen urineren is weer toegenomen)	Nee 	Nvt 	Nvt 	Nee 	Nvt 	Geen 
Onbekend*  	Nog steeds gedeeltelijk werkzaam (nu 10 maanden later) (alleen urineren is weer toegenomen)	Ja; 1 is helemaal verdwenen, de ander sterk verkleind  	Na 2 maanden 	Nog steeds klein (10 maanden later)	Nee 	Nvt 	Hond is in gewicht toegenomen (weegt 34 kg)  
0707066	Na 6 maanden weer interesse in loopse teefjes en meer snuffelen tijdens wandelen 	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend	Hond wordt aantrekkelijk voor andere honden 5 maanden PI 
0602559		Onbekend	Ja 	Na 3 weken 	Onbekend	Onbekend	Onbekend	Onbekend 
0215765	Na ongeveer 1 jaar 	Ja; bijna helemaal verdwenen 	Na ongeveer 1 maand	Nog steeds halve grootte (?? Maanden later)	Nee 	Nvt 	Geen 

Table 3: Changes after chemical castration (3/3) 


Attachment 6: Results of Pilot study (2/3)  

Vetware nummer	Implantaat	Gedrags-verandering	Start verandering(weken)	Einde verandering(maanden)	Testis verkleining	Start verkleining(weken)	Einde verkleining(maanden)	Chirurgische castratie	Effect vergelijkbaar
0606448	6 mnd	Ja	8 	24 	Ja	2	Onbekend	Ja 	Ja 
0802280	6 mnd	Ja	6-8 	5,5	Ja	2	5	Ja 	Ja (zelfs meer)
0800875	6 mnd	Ja	4 	6 	Ja	3-4	Nvt 	Nee 	Nvt
0800439	6 mnd	Ja	6 	7	Ja	3	Nvt 	Nee 	Nvt 
0802804	6 mnd	Ja	6 	6	Ja	6	6	Ja 	Ja 
0800138	6 mnd	Ja	6 	Werkzaam (na 10 mnd)	Nee 	Nvt 	Nvt 	Nee 	Nvt 
Onbekend 	6 mnd	Ja	6 	Werkzaam (na 10 mnd)	Ja	8	Klein (na 10 mnd)	Nee 	Nvt 
0602559	6 mnd	Ja	3 	Onbekend	Ja	3	Onbekend 	Onbekend 	Onbekend 
0801131	12 mnd	Niet heel duidelijk	Onbekend	8	Ja	Onbekend 	Klein (na 9 mnd)	Ja 	Onbekend 
0709405	12 mnd	Ja	1,5 	Werkzaam (na 10 mnd)	Ja	3	Klein (na 10 mnd)	Nee 	Nvt 
0707624	12 mnd	Ja	3 	Werkzaam (na 14 mnd)	Ja	4	13	Nee 	Nvt 
0707977	12 mnd	Onbekend	Onbekend	Onbekend	Ja	Onbekend 	Onbekend 	Onbekend 	Onbekend 
0704608	12 mnd	Ja	1 	6 	Ja	0,5	6	Nee 	Nvt 
0800188	12 mnd	Ja	3 	Werkzaam (na 10 mnd)	Ja	3	Klein (na 10 mnd)	Nee 	Nvt 
0800944	12 mnd	Nee	Nvt 	Werkzaam (na 4 mnd)	Ja	Nvt 	Klein (na 4 mnd)	Nee 	Nvt 
0707623	12 mnd	Ja	5-6 	Werkzaam (na 12 mnd)	Ja	2	12	Nee 	Nvt 
0708533	12 mnd	Ja	Onbekend	Onbekend	Onbekend 	Onbekend 	Onbekend 	Ja 	Onbekend 
0708954	12 mnd	Ja	Direct	Werkzaam (na 10 mnd)	Ja	4	Klein (na 10 mnd)	Nee 	Nvt 
0706080	12 mnd	Ja	4 	12	Ja	6	11	Ja 	Ja 
0707066	12 mnd	Ja	4 	6	Onbekend	Onbekend 	Onbekend 	Onbekend 	Onbekend 
0215765	12 mnd	Niet heel duidelijk	6 	12 	Ja	4	Onbekend 	Nee 	Nvt 

Table 4: Changes after chemical castration for S6 and S12 
Attachment 7: Results of pilot study (3/3) 

Vetware nummer	Wegloop gedrag	Agressie naar mensen	Agressie naar reuen	Agressie naar teven	Urine markeren	Seksueel gedrag	Voorhuid-ontsteking	Overig 
0606448	Nvt 	Nvt 	Afgenomen 	Nvt 	Gelijk 	Helemaal verdwenen	Onbekend 	Slomer
0802280	Afgenomen 	Toegenomen 	Afgenomen 	Afgenomen 	Afgenomen 	Afgenomen 	Helemaal verdwenen	Speelser; beter luisteren; rustiger 
0800875	Nvt 	Nvt 	Toegenomen 	Nvt 	Gelijk 	Helemaal verdwenen	Helemaal verdwenen	
0800439	Helemaal verdwenen	Afgenomen 	Helemaal verdwenen	Nvt 	Afgenomen 	Helemaal verdwenen	Helemaal verdwenen	Beter luisteren; 
0802804	Nvt 	Nvt 	Nvt 	Nvt 	Afgenomen 	Afgenomen 	Onbekend	
0800138	Nvt 	Afgenomen 	Afgenomen 	Afgenomen 	Afgenomen 	Helemaal verdwenen 	Onbekend 	Beter luisteren 
Onbekend 	Nvt 	Afgenomen 	Afgenomen 	Afgenomen 	Afgenomen 	Helemaal verdwenen 	Onbekend 	Beter luisteren 
0602559	Onbekend 	Onbekend 	Onbekend 	Onbekend 	Onbekend 	Helemaal verdwenen 	Onbekend 	Speelser
0801131	Nvt 	Nvt 	Nvt 	Nvt 	Gelijk 	Afgenomen 	Onbekend 	
0709405	Nvt 	Nvt 	Nvt 	Nvt 	Gelijk 	Afgenomen 	Onbekend 	
0707624	Nvt 	Nvt 	Gelijk 	Nvt 	Gelijk 	Nvt 	Onbekend 	Speelser 
0707977	Onbekend 	Onbekend 	Onbekend 	Onbekend 	Onbekend 	Onbekend 	Onbekend 	
0704608	Nvt 	Nvt 	Afgenomen 	Toegenomen 	Afgenomen 	Afgenomen 	Onbekend 	speelser; beter luisteren
0800188	Gelijk 	Nvt 	Nvt 	Nvt 	Toegenomen 	Helemaal verdwenen 	Helemaal verdwenen 	
0800944	Nvt 	Nvt 	Nvt 	Nvt 	Gelijk 	Nvt 	Helemaal verdwenen 	
0707623	Nvt 	Nvt 	Afgenomen 	Nvt 	Nvt 	Nvt 	Onbekend 	
0708533	Onbekend 	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend	Onbekend 	
0708954	Nvt 	Toegenomen 	Toegenomen 	Nvt 	Afgenomen 	Helemaal verdwenen	Onbekend 	Rustiger 
0706080	Nvt 	Nvt 	Nvt 	Nvt 	Afgenomen 	Helemaal verdwenen	Onbekend 	speelser; rustiger; beter luisteren 
0707066	Onbekend 	Nvt 	Nvt 	Nvt 	Onbekend 	Helemaal verdwenen 	Onbekend 	Rustiger; speelser
0215765	Nvt 	Nvt 	Gelijk 	Nvt 	Gelijk 	Nvt 	Onbekend 	

Table 5: Behavioural changes after chemical castration for S6 and S12 


Attachment 8: Results telephonic follow-up (week 1, 3, 5 and 7)  







5. Luisteren naar commando’s	0	3/6	3/6	0	0	0	0		
6. Agressiviteit naar mensen	0	0	0	0	0	0	6/6		
7. Agressiviteit naar reuen	0	1/6	3/6	1/6	0	0	1/6		
8. Agressiviteit naar teven	0	0	0	0	0	0	6/6		
9. Seksueel gedrag	1/6	1/6	1/6	2/6	0	0	1/6		
10. Urine markeren	2/6	0	2/6	2/6	0	0	0		
11. Weglopen tijdens los lopen	0	0	1/6	0	0	0	5/6		




16. Grootte van testes	0	0	6/6	0	0	0			
17. Urine incontinentie								0	6/6
18. Medische complicaties na ingreep								0	6/6











5. Luisteren naar commando’s	1/6	1/6	3/6	1/6	0	0	0		
6. Agressiviteit naar mensen	0	1/6	0	0	0	0	5/6		
7. Agressiviteit naar reuen	0	0	1/6	3/6	1/6	0	1/6		
8. Agressiviteit naar teven	0	0	1/6	0	0	0	5/6		
9. Seksueel gedrag	0	0	0	2/6	0	2/6	2/6		
10. Urine markeren	1/6	0	4/6	1/6	0	0	0		
11. Weglopen tijdens los lopen	0	0	0	2/6	0	0	4/6		




16. Grootte van testes	0	0	2/6	3/6	1/6	0			
17. Urine incontinentie								0	6/6
18. Medische complicaties na ingreep								0	6/6

Table 7: Changes week 3 (6 dogs) 
 





5. Luisteren naar commando’s	0	3/6	2/6	1/6	0	0	0		
6. Agressiviteit naar mensen	0	2/6	0	0	0	0	4/6		
7. Agressiviteit naar reuen	0	0	0	3/6	2/6	0	1/6		
8. Agressiviteit naar teven	0	0	0	0	0	0	6/6		
9. Seksueel gedrag	0	0	0	1/6	0	1/6	4/6		
10. Urine markeren	0	0	3/6	1/6	2/6	0	0		
11. Weglopen tijdens los lopen	0	0	0	0	1/6	1/6	4/6		




16. Grootte van testes	0	0	0	1/6	5/6	0			
17. Urine incontinentie								0	6/6
18. Medische complicaties na ingreep								0	6/6

Table 8: Changes week 5 (6 dogs) 
 





5. Luisteren naar commando’s	1/6	2/6	3/6	0	0	0	0		
6. Agressiviteit naar mensen	0	1/6	1/6	0	0	0	4/6		
7. Agressiviteit naar reuen	1/6	0	0	1/6	2/6	1/6	1/6		
8. Agressiviteit naar teven	0	0	0	0	0	0	6/6		
9. Seksueel gedrag	0	0	0	0	1/6	3/6	2/6		
10. Urine markeren	0	0	3/6	2/6	1/6	0	0		
11. Weglopen tijdens los lopen	0	0	0	1/6	1/6	1/6	3/6		




16. Grootte van testes	0	0	0	1/6	5/6	0			
17. Urine incontinentie								0	6/6
18. Medische complicaties na ingreep								0	6/6

































































Figure 14: Testis circumference, n=6. 

Figure 11: Sexual behaviour, n=6. 

Figure 10: Inter-male aggression, n=6. 

Figure 12: Play behaviour, n=6.

Figure 13: General agility, n=6.

Figure 9: Relationship between behavioural change and testis reduction (S12), n=8

Figure 8: Relationship between behavioural change and testis reduction (S6), n=7.

Figure 4: The ending of behavioural changes after implantation (S6 and S12), S6 n=7 (of which 2 still active), S12 n=11 (of which 6 still active)

Figure 3: The onset of behavioural changes after implantation (S6 and S12), S6 n=8, S12 n=9.

Figure 7: Changes after implantation (pilot study, S12), n=13.

Figure 6: Changes after implantation (pilot study, S6), n=8.

Figure 5: Changes after implantation (pilot study), n=21.

Figure 16: Appetite, n=6. 
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